| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyMolecularFunction | ATP-dependent activity | MYH8 ABCA3 ATP7B CCT3 MYO1E MYO10 MCM3 DDX10 DDX50 HELZ DDX24 SLC27A2 RAD51D MRE11 IPO8 DHX40 MYO19 ABCC9 MYO1B XRCC5 NLRP3 NUBP2 MACF1 | 8.54e-08 | 614 | 204 | 23 | GO:0140657 |
| GeneOntologyMolecularFunction | protein serine kinase activity | SMG1 RPS6KA5 PDPK1 LRRK2 ROCK2 RPS6KA4 HIPK3 MAPK14 PRKAA1 ROCK1 PRKDC MAPK4 MAPK6 IKBKB MAPK13 | 5.22e-06 | 363 | 204 | 15 | GO:0106310 |
| GeneOntologyMolecularFunction | ATP hydrolysis activity | MYH8 ABCA3 ATP7B CCT3 MYO1E MCM3 DDX10 DDX50 DDX24 RAD51D DHX40 MYO19 ABCC9 XRCC5 NLRP3 MACF1 | 1.29e-05 | 441 | 204 | 16 | GO:0016887 |
| GeneOntologyMolecularFunction | MAP kinase activity | 1.75e-05 | 16 | 204 | 4 | GO:0004707 | |
| GeneOntologyMolecularFunction | microfilament motor activity | 4.04e-05 | 38 | 204 | 5 | GO:0000146 | |
| GeneOntologyMolecularFunction | protein serine/threonine kinase activity | SMG1 RPS6KA5 PDPK1 LRRK2 ROCK2 RPS6KA4 HIPK3 MAPK14 PRKAA1 ROCK1 PRKDC MAPK4 MAPK6 IKBKB MAPK13 | 5.77e-05 | 446 | 204 | 15 | GO:0004674 |
| GeneOntologyMolecularFunction | Rho-dependent protein serine/threonine kinase activity | 1.04e-04 | 2 | 204 | 2 | GO:0072518 | |
| GeneOntologyMolecularFunction | ribonucleoside triphosphate phosphatase activity | MYH8 ABCA3 ATP7B CCT3 MYO1E LRRK2 MCM3 DDX10 DDX50 DDX24 RAD51D RASA1 DHX40 MYO19 ABCC9 XRCC5 RGS12 NLRP3 GNB5 MACF1 | 1.40e-04 | 775 | 204 | 20 | GO:0017111 |
| GeneOntologyMolecularFunction | GTPase activator activity | SGSM1 LRRK2 TBC1D4 TBC1D1 ARHGAP29 RGPD5 RASA1 RGS12 GNB5 ARHGAP45 ADAP2 | 1.46e-04 | 279 | 204 | 11 | GO:0005096 |
| GeneOntologyMolecularFunction | histone kinase activity | 1.79e-04 | 28 | 204 | 4 | GO:0035173 | |
| GeneOntologyMolecularFunction | helicase activity | 2.25e-04 | 158 | 204 | 8 | GO:0004386 | |
| GeneOntologyMolecularFunction | chloride:bicarbonate antiporter activity | 2.79e-04 | 13 | 204 | 3 | GO:0140900 | |
| GeneOntologyMolecularFunction | bicarbonate:monoatomic anion antiporter activity | 2.79e-04 | 13 | 204 | 3 | GO:0140829 | |
| GeneOntologyMolecularFunction | monoatomic cation:bicarbonate symporter activity | 2.79e-04 | 13 | 204 | 3 | GO:0140410 | |
| GeneOntologyMolecularFunction | bicarbonate transmembrane transporter activity | 3.04e-04 | 32 | 204 | 4 | GO:0015106 | |
| GeneOntologyMolecularFunction | plus-end directed microfilament motor activity | 3.10e-04 | 3 | 204 | 2 | GO:0060002 | |
| GeneOntologyMolecularFunction | sodium,bicarbonate:chloride antiporter activity | 3.10e-04 | 3 | 204 | 2 | GO:0140892 | |
| GeneOntologyMolecularFunction | histone H3S28 kinase activity | 3.10e-04 | 3 | 204 | 2 | GO:0044022 | |
| GeneOntologyMolecularFunction | phosphotransferase activity, alcohol group as acceptor | SMG1 HK2 RPS6KA5 PDPK1 LRRK2 IDNK ROCK2 RPS6KA4 HIPK3 MAPK14 PRKAA1 DGKI ROCK1 PRKDC MAPK4 MAPK6 IKBKB MAPK13 | 3.70e-04 | 709 | 204 | 18 | GO:0016773 |
| GeneOntologyMolecularFunction | pyrophosphatase activity | MYH8 ABCA3 ATP7B CCT3 MYO1E LRRK2 MCM3 DDX10 DDX50 DDX24 RAD51D RASA1 DHX40 MYO19 ABCC9 XRCC5 RGS12 NLRP3 GNB5 MACF1 | 3.94e-04 | 839 | 204 | 20 | GO:0016462 |
| GeneOntologyMolecularFunction | hydrolase activity, acting on acid anhydrides | MYH8 ABCA3 ATP7B CCT3 MYO1E LRRK2 MCM3 DDX10 DDX50 DDX24 RAD51D RASA1 DHX40 MYO19 ABCC9 XRCC5 RGS12 NLRP3 GNB5 MACF1 | 4.00e-04 | 840 | 204 | 20 | GO:0016817 |
| GeneOntologyMolecularFunction | hydrolase activity, acting on acid anhydrides, in phosphorus-containing anhydrides | MYH8 ABCA3 ATP7B CCT3 MYO1E LRRK2 MCM3 DDX10 DDX50 DDX24 RAD51D RASA1 DHX40 MYO19 ABCC9 XRCC5 RGS12 NLRP3 GNB5 MACF1 | 4.00e-04 | 840 | 204 | 20 | GO:0016818 |
| GeneOntologyMolecularFunction | microtubule minus-end binding | 4.37e-04 | 15 | 204 | 3 | GO:0051011 | |
| GeneOntologyMolecularFunction | gamma-tubulin binding | 5.95e-04 | 38 | 204 | 4 | GO:0043015 | |
| GeneOntologyMolecularFunction | histone H3S10 kinase activity | 6.15e-04 | 4 | 204 | 2 | GO:0035175 | |
| GeneOntologyMolecularFunction | bisphosphoglycerate mutase activity | 6.15e-04 | 4 | 204 | 2 | GO:0004082 | |
| GeneOntologyMolecularFunction | 2,3-bisphosphoglycerate-dependent phosphoglycerate mutase activity | 6.15e-04 | 4 | 204 | 2 | GO:0046538 | |
| GeneOntologyMolecularFunction | phosphoglycerate mutase activity | 6.15e-04 | 4 | 204 | 2 | GO:0004619 | |
| GeneOntologyMolecularFunction | kinase activity | SMG1 HK2 RPS6KA5 PDPK1 LRRK2 IDNK ROCK2 RPS6KA4 HIPK3 MAPK14 PRKAA1 DGKI ROCK1 PRKDC MAPK4 MAPK6 IKBKB MAPK13 | 8.83e-04 | 764 | 204 | 18 | GO:0016301 |
| GeneOntologyMolecularFunction | symporter activity | 9.00e-04 | 150 | 204 | 7 | GO:0015293 | |
| GeneOntologyMolecularFunction | metal cation:monoatomic cation antiporter activity | 9.56e-04 | 43 | 204 | 4 | GO:0140828 | |
| GeneOntologyMolecularFunction | calcium, potassium:sodium antiporter activity | 1.02e-03 | 5 | 204 | 2 | GO:0008273 | |
| GeneOntologyMolecularFunction | metal ion transmembrane transporter activity | ATP7B SLC24A3 RYR3 SLC24A4 KCNH2 CACNA2D1 SLC4A8 SLC11A2 ABCC9 CUL5 LRRC55 SLC39A12 SLC4A10 | 1.03e-03 | 465 | 204 | 13 | GO:0046873 |
| GeneOntologyMolecularFunction | active monoatomic ion transmembrane transporter activity | ATP7B SLC24A3 SLC24A4 SLC4A8 SLC11A2 ABCC9 SLC45A4 SLC39A12 SLC26A7 SLC4A10 | 1.10e-03 | 301 | 204 | 10 | GO:0022853 |
| GeneOntologyMolecularFunction | enzyme activator activity | SGSM1 PDPK1 LRRK2 TBC1D4 TBC1D1 ARHGAP29 RGPD5 ROCK2 RASA1 XRCC5 RGS12 NLRP3 TCL1B GNB5 ARHGAP45 ADAP2 | 1.19e-03 | 656 | 204 | 16 | GO:0008047 |
| GeneOntologyMolecularFunction | protein kinase activity | SMG1 RPS6KA5 PDPK1 LRRK2 ROCK2 RPS6KA4 HIPK3 MAPK14 PRKAA1 ROCK1 PRKDC MAPK4 MAPK6 IKBKB MAPK13 | 1.33e-03 | 600 | 204 | 15 | GO:0004672 |
| GeneOntologyMolecularFunction | tau-protein kinase activity | 1.40e-03 | 22 | 204 | 3 | GO:0050321 | |
| GeneOntologyMolecularFunction | sodium:bicarbonate symporter activity | 1.52e-03 | 6 | 204 | 2 | GO:0008510 | |
| GeneOntologyMolecularFunction | transferase activity, transferring phosphorus-containing groups | SMG1 HK2 RPS6KA5 PDPK1 LRRK2 IDNK ROCK2 RPS6KA4 HIPK3 MAPK14 PRKAA1 DGKI ROCK1 TNKS PRKDC MAPK4 MAPK6 TNKS2 IKBKB MAPK13 | 1.55e-03 | 938 | 204 | 20 | GO:0016772 |
| GeneOntologyMolecularFunction | nucleoside-triphosphatase regulator activity | SGSM1 MYCBP2 LRRK2 TBC1D4 TBC1D1 ARHGAP29 RGPD5 RASA1 RGS12 GNB5 DGKI ARHGAP45 ADAP2 | 2.22e-03 | 507 | 204 | 13 | GO:0060589 |
| GeneOntologyMolecularFunction | GTPase regulator activity | SGSM1 MYCBP2 LRRK2 TBC1D4 TBC1D1 ARHGAP29 RGPD5 RASA1 RGS12 GNB5 DGKI ARHGAP45 ADAP2 | 2.22e-03 | 507 | 204 | 13 | GO:0030695 |
| GeneOntologyMolecularFunction | transmembrane transporter activity | NAT2 ABCA3 ATP7B SLC24A3 RYR3 SLC24A4 TOMM40L KCNH2 SLC27A2 CACNA2D1 SLC4A8 SLC11A2 IPO8 ABCC9 GSDMC SLC45A4 CUL5 LRRC55 SLC39A12 TMEM120A SLC26A7 SLC4A10 LRP6 | 2.23e-03 | 1180 | 204 | 23 | GO:0022857 |
| GeneOntologyMolecularFunction | copper ion transmembrane transporter activity | 2.79e-03 | 8 | 204 | 2 | GO:0005375 | |
| GeneOntologyMolecularFunction | myosin light chain binding | 2.79e-03 | 8 | 204 | 2 | GO:0032027 | |
| GeneOntologyBiologicalProcess | peptidyl-serine phosphorylation | SMG1 RPS6KA5 PDPK1 LRRK2 ROCK2 RPS6KA4 HIPK3 MAPK14 PPM1F PRKAA1 ROCK1 TNKS PRKDC IKBKB MAPK13 | 3.42e-07 | 307 | 200 | 15 | GO:0018105 |
| GeneOntologyBiologicalProcess | peptidyl-serine modification | SMG1 RPS6KA5 PDPK1 LRRK2 ROCK2 RPS6KA4 HIPK3 MAPK14 PPM1F PRKAA1 ROCK1 TNKS PRKDC IKBKB MAPK13 | 5.57e-07 | 319 | 200 | 15 | GO:0018209 |
| GeneOntologyBiologicalProcess | negative regulation of bicellular tight junction assembly | 3.05e-05 | 7 | 200 | 3 | GO:1903347 | |
| GeneOntologyCellularComponent | chromosome, telomeric region | 6.00e-05 | 176 | 204 | 9 | GO:0000781 | |
| Domain | ARM-type_fold | SMG1 CLTCL1 LRRK2 CUL9 PSMD2 RYR3 FOCAD AP2A1 AP2A2 UTP20 TARBP1 EIF3M IPO8 TNPO2 ECPAS CWC22 WDFY4 MROH6 PELP1 CEBPZ PRKDC WDFY3 PUM1 | 3.42e-12 | 339 | 205 | 23 | IPR016024 |
| Domain | ARM-like | SMG1 LRRK2 CUL9 PSMD2 AP2A1 AP2A2 UTP20 TARBP1 IPO8 TNPO2 ECPAS WDFY4 MROH6 PELP1 PRKDC WDFY3 PUM1 | 7.95e-09 | 270 | 205 | 17 | IPR011989 |
| Domain | - | LRRK2 CUL9 PSMD2 AP2A1 AP2A2 UTP20 IPO8 TNPO2 ECPAS WDFY4 MROH6 PRKDC WDFY3 PUM1 | 1.70e-07 | 222 | 205 | 14 | 1.25.10.10 |
| Domain | Cullin_CS | 4.42e-05 | 7 | 205 | 3 | IPR016157 | |
| Domain | Myosin_head_motor_dom | 5.67e-05 | 38 | 205 | 5 | IPR001609 | |
| Domain | MYOSIN_MOTOR | 5.67e-05 | 38 | 205 | 5 | PS51456 | |
| Domain | Myosin_head | 5.67e-05 | 38 | 205 | 5 | PF00063 | |
| Domain | MYSc | 5.67e-05 | 38 | 205 | 5 | SM00242 | |
| Domain | Cullin_neddylation_domain | 7.01e-05 | 8 | 205 | 3 | IPR019559 | |
| Domain | Cullin_Nedd8 | 7.01e-05 | 8 | 205 | 3 | PF10557 | |
| Domain | Cullin_Nedd8 | 7.01e-05 | 8 | 205 | 3 | SM00884 | |
| Domain | PH_dom-like | MYO10 PDPK1 TBC1D4 TBC1D1 PLCL1 RGPD5 ANKS1A ROCK2 RASA1 MYO1B WDFY4 RGS12 ROCK1 WDFY3 ADAP2 | 7.65e-05 | 426 | 205 | 15 | IPR011993 |
| Domain | Cullin_homology | 1.04e-04 | 9 | 205 | 3 | IPR016158 | |
| Domain | - | 1.20e-04 | 2 | 205 | 2 | 2.60.40.1030 | |
| Domain | Rho_Binding | 1.20e-04 | 2 | 205 | 2 | PF08912 | |
| Domain | Rho-bd_dom | 1.20e-04 | 2 | 205 | 2 | IPR015008 | |
| Domain | Clathrin_a-adaptin_app_Ig-like | 1.20e-04 | 2 | 205 | 2 | IPR013038 | |
| Domain | DUF3350 | 1.20e-04 | 2 | 205 | 2 | PF11830 | |
| Domain | DUF3350 | 1.20e-04 | 2 | 205 | 2 | IPR021785 | |
| Domain | ROCK1/ROCK2 | 1.20e-04 | 2 | 205 | 2 | IPR020684 | |
| Domain | AP2_complex_asu | 1.20e-04 | 2 | 205 | 2 | IPR017104 | |
| Domain | Clathrin_a-adaptin_app_sub_C | 1.20e-04 | 2 | 205 | 2 | IPR003164 | |
| Domain | Alpha_adaptin_C | 1.20e-04 | 2 | 205 | 2 | PF02296 | |
| Domain | Cullin | 1.48e-04 | 10 | 205 | 3 | PF00888 | |
| Domain | CULLIN_2 | 1.48e-04 | 10 | 205 | 3 | PS50069 | |
| Domain | Cullin_N | 1.48e-04 | 10 | 205 | 3 | IPR001373 | |
| Domain | CULLIN_1 | 1.48e-04 | 10 | 205 | 3 | PS01256 | |
| Domain | Ser/Thr_kinase_AS | RPS6KA5 PDPK1 LRRK2 ROCK2 RPS6KA4 HIPK3 MAPK14 PRKAA1 ROCK1 MAPK4 MAPK6 IKBKB MAPK13 | 1.66e-04 | 357 | 205 | 13 | IPR008271 |
| Domain | S_TKc | RPS6KA5 PDPK1 LRRK2 ROCK2 RPS6KA4 HIPK3 MAPK14 PRKAA1 ROCK1 MAPK4 MAPK6 IKBKB MAPK13 | 1.76e-04 | 359 | 205 | 13 | SM00220 |
| Domain | PROTEIN_KINASE_ST | RPS6KA5 PDPK1 LRRK2 ROCK2 RPS6KA4 HIPK3 MAPK14 PRKAA1 ROCK1 MAPK4 MAPK6 IKBKB MAPK13 | 1.91e-04 | 362 | 205 | 13 | PS00108 |
| Domain | Pkinase | RPS6KA5 PDPK1 LRRK2 ROCK2 RPS6KA4 HIPK3 MAPK14 PRKAA1 ROCK1 MAPK4 MAPK6 IKBKB MAPK13 | 3.13e-04 | 381 | 205 | 13 | PF00069 |
| Domain | Kinase-like_dom | SMG1 RPS6KA5 PDPK1 LRRK2 ROCK2 RPS6KA4 HIPK3 MAPK14 PRKAA1 MACF1 ROCK1 PRKDC MAPK4 MAPK6 IKBKB MAPK13 | 3.33e-04 | 542 | 205 | 16 | IPR011009 |
| Domain | MAPK_ERK3/4 | 3.57e-04 | 3 | 205 | 2 | IPR008350 | |
| Domain | PID | 3.98e-04 | 32 | 205 | 4 | PS01179 | |
| Domain | ZF_DAG_PE_1 | 6.84e-04 | 64 | 205 | 5 | PS00479 | |
| Domain | ZF_DAG_PE_2 | 6.84e-04 | 64 | 205 | 5 | PS50081 | |
| Domain | Pkinase_C | 7.01e-04 | 37 | 205 | 4 | IPR017892 | |
| Domain | Clathrin_a/coatomer_app_sub_C | 7.09e-04 | 4 | 205 | 2 | IPR015873 | |
| Domain | MAPK_p38 | 7.09e-04 | 4 | 205 | 2 | IPR008352 | |
| Domain | - | 7.09e-04 | 4 | 205 | 2 | 3.30.310.30 | |
| Domain | Phosphogly_mut1 | 7.09e-04 | 4 | 205 | 2 | IPR005952 | |
| Domain | C1 | 7.35e-04 | 65 | 205 | 5 | SM00109 | |
| Domain | PE/DAG-bd | 7.88e-04 | 66 | 205 | 5 | IPR002219 | |
| Domain | PTB | 9.45e-04 | 40 | 205 | 4 | SM00462 | |
| Domain | Protein_kinase_ATP_BS | RPS6KA5 PDPK1 LRRK2 ROCK2 RPS6KA4 HIPK3 MAPK14 PRKAA1 ROCK1 MAPK4 MAPK6 MAPK13 | 1.02e-03 | 379 | 205 | 12 | IPR017441 |
| Domain | HEAT_REPEAT | 1.03e-03 | 70 | 205 | 5 | PS50077 | |
| Domain | PTB/PI_dom | 1.04e-03 | 41 | 205 | 4 | IPR006020 | |
| Domain | P-loop_NTPase | MYH8 ABCA3 MYO1E MYO10 GIMAP2 LRRK2 MCM3 IDNK DDX10 DDX50 HELZ DDX24 RAD51D DHX40 MYO19 ABCC9 MYO1B NLRP3 NUBP2 DSEL | 1.09e-03 | 848 | 205 | 20 | IPR027417 |
| Domain | Pkinase_C | 1.14e-03 | 42 | 205 | 4 | PF00433 | |
| Domain | Na/HCO3_transpt | 1.17e-03 | 5 | 205 | 2 | IPR003024 | |
| Domain | Spc97_Spc98 | 1.17e-03 | 5 | 205 | 2 | PF04130 | |
| Domain | GCP | 1.17e-03 | 5 | 205 | 2 | IPR007259 | |
| Domain | FATC | 1.17e-03 | 5 | 205 | 2 | PF02260 | |
| Domain | K/Na/Ca-exchanger | 1.17e-03 | 5 | 205 | 2 | IPR004481 | |
| Domain | SAM_2 | 1.24e-03 | 43 | 205 | 4 | PF07647 | |
| Domain | PROTEIN_KINASE_ATP | RPS6KA5 PDPK1 LRRK2 ROCK2 RPS6KA4 HIPK3 MAPK14 PRKAA1 ROCK1 MAPK4 MAPK6 IKBKB MAPK13 | 1.73e-03 | 459 | 205 | 13 | PS00107 |
| Domain | FAT | 1.75e-03 | 6 | 205 | 2 | PS51189 | |
| Domain | FATC | 1.75e-03 | 6 | 205 | 2 | PS51190 | |
| Domain | FATC_dom | 1.75e-03 | 6 | 205 | 2 | IPR003152 | |
| Domain | Ribosomal_S6_kinase_II | 1.75e-03 | 6 | 205 | 2 | IPR016239 | |
| Domain | PIK_FAT | 1.75e-03 | 6 | 205 | 2 | IPR014009 | |
| Domain | FATC | 1.75e-03 | 6 | 205 | 2 | SM01343 | |
| Domain | HEAT | 1.88e-03 | 48 | 205 | 4 | PF02985 | |
| Domain | - | 1.88e-03 | 48 | 205 | 4 | 2.120.10.80 | |
| Domain | WD40_repeat_CS | 2.26e-03 | 164 | 205 | 7 | IPR019775 | |
| Domain | APC_su10/DOC_dom | 2.43e-03 | 7 | 205 | 2 | IPR004939 | |
| Domain | DOC | 2.43e-03 | 7 | 205 | 2 | PS51284 | |
| Domain | CULLIN | 2.43e-03 | 7 | 205 | 2 | SM00182 | |
| Domain | ANAPC10 | 2.43e-03 | 7 | 205 | 2 | PF03256 | |
| Domain | ANION_EXCHANGER_2 | 2.43e-03 | 7 | 205 | 2 | PS00220 | |
| Domain | Myosin_TH1 | 2.43e-03 | 7 | 205 | 2 | PF06017 | |
| Domain | ANION_EXCHANGER_1 | 2.43e-03 | 7 | 205 | 2 | PS00219 | |
| Domain | Myosin_TH1 | 2.43e-03 | 7 | 205 | 2 | IPR010926 | |
| Domain | TH1 | 2.43e-03 | 7 | 205 | 2 | PS51757 | |
| Domain | APC10 | 2.43e-03 | 7 | 205 | 2 | SM01337 | |
| Pathway | WP_INSULIN_SIGNALING | RPS6KA5 PDPK1 TBC1D4 RPS6KA4 MAPK14 PRKAA1 MAPK4 MAPK6 IKBKB MAPK13 | 8.02e-06 | 160 | 150 | 10 | MM15956 |
| Pathway | WP_INSULIN_SIGNALING | RPS6KA5 PDPK1 TBC1D4 RPS6KA4 MAPK14 PRKAA1 MAPK4 MAPK6 IKBKB MAPK13 | 8.02e-06 | 160 | 150 | 10 | M39482 |
| Pathway | BIOCARTA_MAPK_PATHWAY | 2.42e-05 | 81 | 150 | 7 | M13863 | |
| Pathway | WP_OSTEOBLAST_DIFFERENTIATION_AND_RELATED_DISEASES | 3.71e-05 | 118 | 150 | 8 | M39852 | |
| Pathway | WP_NONHOMOLOGOUS_END_JOINING | 4.01e-05 | 7 | 150 | 3 | MM15989 | |
| Pathway | WP_ANGIOPOIETINLIKE_PROTEIN_8_REGULATORY_PATHWAY | 8.25e-05 | 132 | 150 | 8 | M39338 | |
| Pathway | WP_MICRORNAS_IN_CARDIOMYOCYTE_HYPERTROPHY | 8.82e-05 | 99 | 150 | 7 | MM15905 | |
| Pathway | WP_MICRORNAS_IN_CARDIOMYOCYTE_HYPERTROPHY | 1.20e-04 | 104 | 150 | 7 | M39625 | |
| Pathway | BIOCARTA_MAPK_PATHWAY | 1.55e-04 | 76 | 150 | 6 | MM1433 | |
| Pathway | WP_MAPK_SIGNALING | RPS6KA5 LRRK2 NFKB2 FGF5 CACNA2D1 RPS6KA4 RASA1 MAPK14 IKBKB MAPK13 | 3.01e-04 | 246 | 150 | 10 | M39597 |
| Pathway | KEGG_NON_HOMOLOGOUS_END_JOINING | 3.12e-04 | 13 | 150 | 3 | M7857 | |
| Pathway | REACTOME_IRF3_MEDIATED_INDUCTION_OF_TYPE_I_IFN | 3.12e-04 | 13 | 150 | 3 | M27240 | |
| Pathway | REACTOME_NUCLEOTIDE_BINDING_DOMAIN_LEUCINE_RICH_REPEAT_CONTAINING_RECEPTOR_NLR_SIGNALING_PATHWAYS | 3.15e-04 | 56 | 150 | 5 | M1074 | |
| Pubmed | CCT3 RRP1B MYCBP2 ZC3H13 UGGT1 CUL9 PSMD2 ACTN1 ANKHD1 PGAM1 DDX10 UTP15 HELZ UTP20 DDX24 CUL4B MRE11 COPA NUP98 MYO1B ECPAS XRCC5 PELP1 CEBPZ FANCI GEMIN4 MACF1 PRKDC PUM1 CNOT1 | 5.36e-18 | 653 | 208 | 30 | 22586326 | |
| Pubmed | Gain of Additional BIRC3 Protein Functions through 3'-UTR-Mediated Protein Complex Formation. | HK2 CCT3 RRP1B UGGT1 MCM3 PSMD2 DARS1 ANKHD1 PGAM1 USP19 DDX10 UBE4A AP2A1 DDX50 AP2A2 UTP15 UTP20 TDRD6 DDX24 EIF3M MRE11 IPO8 COPA NUP98 MYO1B ECPAS XRCC5 NCAPH CWC22 NMD3 PELP1 CEBPZ FANCI DNAJC11 GEMIN4 PRKDC PUM1 CNOT1 NBR1 | 1.58e-15 | 1425 | 208 | 39 | 30948266 |
| Pubmed | Proteomic profiling of VCP substrates links VCP to K6-linked ubiquitylation and c-Myc function. | DNAJB11 HK2 CCT3 MYCBP2 MCM3 PSMD2 DARS1 ACTN1 ANKHD1 DDX10 TBC1D4 AP2A1 DDX50 AP2A2 UTP15 NFKB2 UTP20 DDX24 EIF3M MRE11 COPA KRT18 DHX40 MYO19 MYO1B XRCC5 NCAPH NMD3 CEBPZ FANCI PPM1F GEMIN4 MACF1 PRKDC WDFY3 PUM1 | 5.24e-14 | 1353 | 208 | 36 | 29467282 |
| Pubmed | SMG1 DNAJB11 CLTCL1 HK2 CCT3 MYO1E RRP1B UGGT1 MCM3 PSMD2 TUBGCP4 UBE4A DDX50 AP2A2 NFKB2 DDX24 EIF3M SLC27A2 CACNA2D1 IPO8 COPA KRT18 TNPO2 MYO19 MYO1B ECPAS XRCC5 NCAPH CUL5 PELP1 CEBPZ FANCI GEMIN4 PRKDC IKBKB CNOT1 | 3.29e-13 | 1440 | 208 | 36 | 30833792 | |
| Pubmed | DNAJB11 HK2 AP2A1 AP2A2 UTP15 EIF3M CUL4B COPA MYO1B ECPAS XRCC5 NCAPH NUBP2 CEBPZ DNAJC11 PRKAA1 PUM1 | 1.38e-11 | 323 | 208 | 17 | 24797263 | |
| Pubmed | DNAJB11 MAN1A1 CLTCL1 HK2 ATP7B MYCBP2 MCM3 PSMD2 DARS1 TUBGCP4 PGAM1 AP2A1 DDX50 HELZ DDX24 SLC11A2 COPA ECPAS XRCC5 NCAPH NMD3 TUBGCP6 ORC2 PELP1 FANCI GEMIN4 PRKDC ARHGAP45 CNOT1 NBR1 | 2.01e-11 | 1168 | 208 | 30 | 19946888 | |
| Pubmed | Targeting USP10 induces degradation of oncogenic ANLN in esophageal squamous cell carcinoma. | CCT3 MYO1E RRP1B ZC3H13 UGGT1 MCM3 PSMD2 DARS1 ACTN1 AP2A1 DDX50 UTP15 UTP20 DDX24 EIF3M MRE11 RPS6KA4 COPA KRT18 NUP98 MYO1B XRCC5 NCAPH CWC22 THOC5 PELP1 CEBPZ DNAJC11 GEMIN4 PRKDC | 1.19e-10 | 1257 | 208 | 30 | 36526897 |
| Pubmed | Identifying biological pathways that underlie primordial short stature using network analysis. | DNAJB11 CCT3 RRP1B MYCBP2 UGGT1 MCM3 PSMD2 DARS1 ACTN1 DDX10 AP2A1 DDX50 UTP20 MRE11 CACNA2D1 COPA KRT18 NUP98 MYO1B XRCC5 PELP1 CEBPZ PRKAA1 MACF1 PRKDC PUM1 CNOT1 | 1.26e-10 | 1024 | 208 | 27 | 24711643 |
| Pubmed | A high-throughput approach for measuring temporal changes in the interactome. | DNAJB11 HK2 CCT3 MYO1E UGGT1 BCAT1 MCM3 PSMD2 DARS1 ACTN1 USP19 TBC1D4 EIF3M ANKS1A CUL4B ROCK2 MRE11 COPA KRT18 NUP98 ECPAS XRCC5 NCAPH NUBP2 CUL5 MAPK14 FANCI MACF1 ROCK1 PRKDC IKBKB CNOT1 | 2.09e-10 | 1455 | 208 | 32 | 22863883 |
| Pubmed | UGGT1 PSMD2 TUBGCP4 UBE4A AP2A1 AP2A2 DDX24 CUL4B COPA TNPO2 MYO1B ECPAS CWC22 THOC5 INTS10 PELP1 FANCI PRKAA1 PUM1 CNOT1 | 2.19e-10 | 560 | 208 | 20 | 35241646 | |
| Pubmed | Tumor suppressor BAP1 nuclear import is governed by transportin-1. | DNAJB11 HINT1 CCT3 MYCBP2 TCP11L1 UGGT1 MCM3 PSMD2 DARS1 ACTN1 ANKHD1 PGAM1 TBC1D4 AP2A1 AP2A2 MRE11 COPA KRT18 TNPO2 MYO1B ECPAS XRCC5 NCAPH FANCI GEMIN4 MACF1 PRKDC CNOT1 | 3.30e-10 | 1149 | 208 | 28 | 35446349 |
| Pubmed | Assembly of the U5 snRNP component PRPF8 is controlled by the HSP90/R2TP chaperones. | HK2 CCT3 MYO1E RRP1B UGGT1 MCM3 PSMD2 DARS1 ACTN1 ANKHD1 TBC1D4 AP2A1 AP2A2 DDX24 TARBP1 EIF3M ROCK2 MRE11 COPA KRT18 PRSS56 XRCC5 NCAPH NUBP2 PELP1 CEBPZ PRKAA1 GEMIN4 MACF1 PRKDC NBR1 | 4.54e-10 | 1415 | 208 | 31 | 28515276 |
| Pubmed | CCT3 MCM3 PSMD2 DARS1 ACTN1 USP19 TBC1D4 CUL4B MRE11 IPO8 COPA NUP98 ECPAS XRCC5 PELP1 FANCI GEMIN4 PRKDC PUM1 CNOT1 | 2.06e-09 | 638 | 208 | 20 | 33239621 | |
| Pubmed | CCT3 MCM3 PSMD2 DARS1 PGAM1 ARHGAP29 FAM135A ANKS1A ROCK2 MRE11 COPA MYO1B ECPAS XRCC5 FANCI GEMIN4 LRP6 MACF1 ROCK1 PRKDC CNOT1 | 2.13e-09 | 708 | 208 | 21 | 39231216 | |
| Pubmed | HK2 MCM3 PSMD2 HIC2 PGAM1 AP2A1 DDX50 AP2A2 EIF3M CUL4B ROCK2 COPA ECPAS XRCC5 TFAP2C NMD3 PELP1 ROCK1 PRKDC PUM1 | 3.06e-09 | 653 | 208 | 20 | 33742100 | |
| Pubmed | Proteome-wide identification of HSP70/HSC70 chaperone clients in human cells. | HINT1 CCT3 RRP1B UGGT1 FAM114A2 PSMD2 DARS1 ACTN1 PGAM1 USP19 AP2A1 UTP15 DDX24 EIF3M ROCK2 MRE11 IPO8 COPA KRT18 NUP98 ECPAS XRCC5 NCAPH PDLIM4 PELP1 PRKAA1 ROCK1 PRKDC CNOT1 | 3.63e-09 | 1367 | 208 | 29 | 32687490 |
| Pubmed | PDPK1 PSMD2 ACTN1 USP19 RMI1 AP2A1 AP2A2 USP32 ARHGAP29 SLC27A2 HSPG2 HECTD4 CUL5 TMEM120A MACF1 IKBKB NBR1 | 6.10e-09 | 481 | 208 | 17 | 28190767 | |
| Pubmed | BAP1 regulation of the key adaptor protein NCoR1 is critical for γ-globin gene repression. | CCT3 RRP1B ZC3H13 MCM3 PSMD2 DARS1 DDX10 AP2A1 DDX50 AP2A2 UTP15 HELZ DDX24 EIF3M MRE11 COPA NUP98 XRCC5 NCAPH CWC22 NUBP2 NMD3 ORC2 TAF3 CEBPZ DNAJC11 PRKDC PUM1 | 6.73e-09 | 1318 | 208 | 28 | 30463901 |
| Pubmed | MYC multimers shield stalled replication forks from RNA polymerase. | CCT3 RRP1B MCM3 PSMD2 ACTN1 DDX10 DDX50 UTP15 NFKB2 UTP20 DDX24 EIF3M COPA KRT18 DHX40 PRSS56 MYO1B XRCC5 CWC22 NMD3 PELP1 CEBPZ FANCI PRKDC | 7.27e-09 | 989 | 208 | 24 | 36424410 |
| Pubmed | LGALS3BP regulates centriole biogenesis and centrosome hypertrophy in cancer cells. | SMG1 DNAJB11 CLTCL1 CCT3 RRP1B UGGT1 CUL9 TUBGCP4 TBC1D4 CEP78 HELZ DDX24 RBL2 TUBGCP6 FANCI SLC4A10 PRKDC MAPK6 PUM1 | 1.24e-08 | 639 | 208 | 19 | 23443559 |
| Pubmed | LMBR1L regulates lymphopoiesis through Wnt/β-catenin signaling. | MAN1A1 HK2 PSMD2 USP19 DDX10 AP2A1 CEP78 UTP20 TARBP1 COPA KRT18 NUP98 ECPAS NMD3 CEBPZ FANCI PPM1F DNAJC11 GEMIN4 LRP6 PRKDC PUM1 NBR1 | 1.37e-08 | 942 | 208 | 23 | 31073040 |
| Pubmed | TBK1 phosphorylation activates LIR-dependent degradation of the inflammation repressor TNIP1. | DNAJB11 CCT3 MYO1E RRP1B MYO10 MCM3 PSMD2 DARS1 ACTN1 DDX10 AP2A1 DDX50 AP2A2 UTP15 UTP20 RPS6KA4 COPA KRT18 MYO1B XRCC5 CEBPZ GEMIN4 PRKDC | 1.57e-08 | 949 | 208 | 23 | 36574265 |
| Pubmed | DNAJB11 CCT3 RRP1B MYCBP2 UGGT1 PSMD2 TBC1D4 DDX50 HELZ COPA KRT18 NUP98 MYO1B PTPRU MAPK14 CEBPZ FANCI PPM1F LRP6 UBR3 ROCK1 PUM1 CNOT1 NBR1 | 2.23e-08 | 1049 | 208 | 24 | 27880917 | |
| Pubmed | SMG1 RRP1B HIC2 ADGRV1 ANKHD1 ZBTB5 WDR90 ANKS1A HECTD4 KBTBD2 ECPAS NCAPH CWC22 TUBGCP6 PPM1F CNOT1 NBR1 | 2.45e-08 | 529 | 208 | 17 | 14621295 | |
| Pubmed | The functional interactome of PYHIN immune regulators reveals IFIX is a sensor of viral DNA. | RRP1B DDX10 DDX50 UTP15 HELZ UTP20 DDX24 MRE11 HSPG2 COPA XRCC5 TFAP2C PELP1 CEBPZ | 2.92e-08 | 349 | 208 | 14 | 25665578 |
| Pubmed | DNAJB11 CCT3 MCM3 PSMD2 DARS1 AP2A1 AP2A2 COPA MYO1B XRCC5 DNAJC11 PRKDC | 3.20e-08 | 244 | 208 | 12 | 28902428 | |
| Pubmed | SMG1 MYH8 CLTCL1 CCT3 UGGT1 FAM114A2 PSMD2 ACTN1 PDE10A PGAM1 AP2A1 DDX50 AP2A2 PGAM4 RGPD5 ROCK2 COPA KRT18 NUP98 CCDC127 MYO1B XRCC5 NCAPH CEBPZ DNAJC11 MACF1 PRKDC MAPK6 | 4.52e-08 | 1442 | 208 | 28 | 35575683 | |
| Pubmed | MCM3 PSMD2 ACTN1 USP19 TARBP1 CUL4B COPA DHX40 NUP98 FUOM FANCI GNB5 IKBKB EDRF1 | 4.76e-08 | 363 | 208 | 14 | 25036637 | |
| Pubmed | Large-scale characterization of HeLa cell nuclear phosphoproteins. | RPS6KA5 MYCBP2 PDPK1 ZC3H13 MCM3 USP19 TBC1D4 HELZ UTP20 DDX24 ANKS1A CUL4B ROCK2 MRE11 COPA NUP98 ECPAS TUBGCP6 TAF3 PRKDC | 5.11e-08 | 774 | 208 | 20 | 15302935 |
| Pubmed | Proteomic analyses reveal distinct chromatin-associated and soluble transcription factor complexes. | HK2 CUL9 HIC2 DARS1 ANKHD1 UBE4A TBC1D4 NFKB2 UTP20 DDX24 NOTCH3 MRE11 COPA RBL2 NUP98 ECPAS NCAPH ORC2 PELP1 PUM1 NBR1 | 5.71e-08 | 857 | 208 | 21 | 25609649 |
| Pubmed | DNAJB11 HK2 UGGT1 CUL9 DARS1 AP2A1 DDX50 AP2A2 DDX24 CUL4B RAD51D MYO19 MYO1B ECPAS XRCC5 THOC5 FANCI MACF1 | 6.11e-08 | 634 | 208 | 18 | 34591612 | |
| Pubmed | A Human Tyrosine Phosphatase Interactome Mapped by Proteomic Profiling. | DNAJB11 RRP1B UGGT1 PSMD2 ANKHD1 AP2A1 HELZ ROCK2 MRE11 IPO8 DHX40 NUP98 PTPRU FUOM ECPAS MAPK14 FANCI DNAJC11 PRKAA1 GEMIN4 TNKS PRKDC | 1.11e-07 | 974 | 208 | 22 | 28675297 |
| Pubmed | 1.53e-07 | 9 | 208 | 4 | 23979601 | ||
| Pubmed | 2.11e-07 | 3 | 208 | 3 | 17012370 | ||
| Pubmed | Choline Uptake and Metabolism Modulate Macrophage IL-1β and IL-18 Production. | 2.11e-07 | 3 | 208 | 3 | 30982734 | |
| Pubmed | 2.33e-07 | 144 | 208 | 9 | 35681168 | ||
| Pubmed | MYO1E MYCBP2 CUL9 PSMD2 DARS1 ACTN1 RYR3 CNOT8 FOCAD UBE4A AP2A1 USP32 ZBTB5 TARBP1 BRWD1 COPA RBL2 TNPO2 HECTD4 FEZ1 MACF1 TNKS PRKDC WDFY3 TNKS2 | 2.45e-07 | 1285 | 208 | 25 | 35914814 | |
| Pubmed | 2.81e-07 | 107 | 208 | 8 | 30995489 | ||
| Pubmed | The protein network surrounding the human telomere repeat binding factors TRF1, TRF2, and POT1. | DNAJB11 MYO10 ZC3H13 ACTN1 AP2A2 TDRD6 DHX40 XRCC5 MACF1 TNKS | 3.43e-07 | 197 | 208 | 10 | 20811636 |
| Pubmed | USP11 mediates repair of DNA-protein cross-links by deubiquitinating SPRTN metalloprotease. | DNAJB11 CCT3 MCM3 PSMD2 DARS1 CNOT8 DDX24 MRE11 COPA DHX40 MYO1B XRCC5 CEBPZ PPM1F DNAJC11 PRKDC | 3.52e-07 | 565 | 208 | 16 | 33567341 |
| Pubmed | A Degradation Motif in STAU1 Defines a Novel Family of Proteins Involved in Inflammation. | MYO1E MYCBP2 DARS1 ANKHD1 PGAM1 CNOT8 DDX10 CEP78 HELZ DDX24 MRE11 COPA THOC5 CEBPZ PRKAA1 MACF1 PUM1 CNOT1 | 4.30e-07 | 724 | 208 | 18 | 36232890 |
| Pubmed | Loss of ER retention motif of AGR2 can impact mTORC signaling and promote cancer metastasis. | CLTCL1 CCT3 MYCBP2 UGGT1 MCM3 PSMD2 DARS1 ACTN1 PGAM1 DUOX1 AP2A1 AP2A2 COPA MYO1B ECPAS XRCC5 MACF1 PRKDC CNOT1 | 4.61e-07 | 807 | 208 | 19 | 30575818 |
| Pubmed | Comparative interactome analysis of α-arrestin families in human and Drosophila. | ABCA3 MYO1E CUL9 MCM3 PSMD2 DDX50 CEP78 CACNA2D1 COPA MYO1B FANCI GEMIN4 | 4.72e-07 | 313 | 208 | 12 | 38270169 |
| Pubmed | ENPP6 HK2 RPS6KA5 PGAM1 AP2A1 AP2A2 KCNH2 PGAM4 PLCL1 CUL4B RPS6KA4 PTPRU HIPK3 MAPK14 ADAM33 MAPK4 MAPK6 MAPK13 | 4.84e-07 | 730 | 208 | 18 | 34857952 | |
| Pubmed | SMG1 CCT3 RRP1B CUL9 PSMD2 HIC2 DARS1 ANKHD1 CNOT8 DDX10 DDX50 NFKB2 HELZ DDX24 MRE11 HSPG2 COPA TNPO2 DHX40 NUP98 MYO1B XRCC5 TAF3 LRP6 PUM1 CNOT1 | 4.95e-07 | 1429 | 208 | 26 | 35140242 | |
| Pubmed | ATPase-Modulated Stress Granules Contain a Diverse Proteome and Substructure. | CCT3 PSMD2 DDX50 HELZ EIF3M TNPO2 NUP98 CWC22 PDLIM4 MACF1 PUM1 CNOT1 | 5.04e-07 | 315 | 208 | 12 | 26777405 |
| Pubmed | ZC3H13 ZBTB5 C1R EIF3M ANKS1A IPO8 DHX40 ADGRL1 KBTBD2 CWC22 CEBPZ ROCK1 MAPK6 | 5.34e-07 | 378 | 208 | 13 | 34315543 | |
| Pubmed | 5.93e-07 | 12 | 208 | 4 | 20805296 | ||
| Pubmed | SMG1 MYCBP2 BCAT1 AP2A1 AP2A2 TBC1D1 HSPG2 CCDC127 CUL5 HIPK3 PELP1 MACF1 ROCK1 TNKS2 PUM1 MAPK13 | 6.37e-07 | 591 | 208 | 16 | 15231748 | |
| Pubmed | Comparative host-coronavirus protein interaction networks reveal pan-viral disease mechanisms. | ATP7B MYO1E MYCBP2 UGGT1 DDX10 AP2A2 UTP20 IL17RA EIF3M SLC27A2 MRE11 IPO8 TNPO2 NUP98 ECPAS CEBPZ FANCI DNAJC11 | 7.69e-07 | 754 | 208 | 18 | 33060197 |
| Pubmed | Defining the human deubiquitinating enzyme interaction landscape. | MYCBP2 MYO10 PSMD2 USP19 DDX10 USP32 DDX24 TARBP1 EIF3M RGPD5 CUL4B MRE11 COPA KRT18 DHX40 NUP98 NMD3 CUL5 FANCI TNKS CNOT1 | 7.76e-07 | 1005 | 208 | 21 | 19615732 |
| Pubmed | CCT3 MYO1E RRP1B DARS1 ANKHD1 CEP78 NFKB2 CUL4B MRE11 HSPG2 COPA MYO1B PRKAA1 MACF1 PRKDC PUM1 | 7.94e-07 | 601 | 208 | 16 | 33658012 | |
| Pubmed | 8.40e-07 | 4 | 208 | 3 | 25233930 | ||
| Pubmed | 8.40e-07 | 4 | 208 | 3 | 23566117 | ||
| Pubmed | The E3 ubiquitin ligase HECTD1 contributes to cell proliferation through an effect on mitosis. | RRP1B MYCBP2 DARS1 DDX10 AP2A1 DDX50 CEP78 UTP15 UTP20 DDX24 IPO8 COPA XRCC5 PELP1 CEBPZ MACF1 PRKDC CNOT1 | 8.45e-07 | 759 | 208 | 18 | 35915203 |
| Pubmed | DNAJB11 HK2 RRP1B MYCBP2 UGGT1 CUL4B IPO8 MYO19 MYO1B NUBP2 TUBGCP6 VPS13D FANCI PPM1F DNAJC11 PUM1 | 8.84e-07 | 606 | 208 | 16 | 36538041 | |
| Pubmed | MYH8 CCT3 TCP11L1 MCM3 PSMD2 DARS1 ACTN1 AP2A1 AP2A2 RGPD5 CUL4B HSPG2 KRT18 XRCC5 HMCN1 PELP1 PRKAA1 MACF1 PRKDC | 9.00e-07 | 844 | 208 | 19 | 25963833 | |
| Pubmed | Two-Dimensional Fractionation Method for Proteome-Wide Cross-Linking Mass Spectrometry Analysis. | CLTCL1 CCT3 RRP1B ZC3H13 MCM3 ACTN1 PGAM1 EIF3M BRWD1 CUL4B ROCK2 MRE11 COPA XRCC5 NCAPH DNAJC11 MACF1 ROCK1 PRKDC | 9.48e-07 | 847 | 208 | 19 | 35235311 |
| Pubmed | DNAJB11 CCT3 AP2A1 NFKB2 RPS6KA4 RBL2 NUP98 MYO1B XRCC5 MAPK14 PRKAA1 PRKDC IKBKB | 1.03e-06 | 401 | 208 | 13 | 25852190 | |
| Pubmed | Phospho-proteomic analyses of B-Raf protein complexes reveal new regulatory principles. | 1.13e-06 | 89 | 208 | 7 | 27034005 | |
| Pubmed | 1.19e-06 | 14 | 208 | 4 | 12239168 | ||
| Pubmed | CCT3 ACTN1 ANKHD1 CNOT8 AP2A2 NFKB2 NCAPH NMD3 CUL5 FANCI MAPK13 | 1.48e-06 | 288 | 208 | 11 | 23383273 | |
| Pubmed | CCT3 MYCBP2 MCM3 AP2A1 AP2A2 PLCL1 ANKS1A ROCK2 CACNA2D1 SLC4A8 HECTD4 XRCC5 PELP1 DZIP3 DGKI MACF1 ROCK1 TNKS WDFY3 CNOT1 | 1.58e-06 | 963 | 208 | 20 | 28671696 | |
| Pubmed | p62-Dependent Phase Separation of Patient-Derived KEAP1 Mutations and NRF2. | 1.61e-06 | 15 | 208 | 4 | 30126895 | |
| Pubmed | Regulation of epidermal differentiation through KDF1-mediated deubiquitination of IKKα. | 1.67e-06 | 182 | 208 | 9 | 32239614 | |
| Pubmed | CCT3 UGGT1 MCM3 PSMD2 DARS1 ACTN1 ANKHD1 PGAM1 TBC1D4 AP2A1 AP2A2 CEP78 DDX24 EIF3M CUL4B MRE11 IPO8 DHX40 XRCC5 NMD3 CUL5 ORC2 MAPK14 PRKDC | 1.74e-06 | 1335 | 208 | 24 | 29229926 | |
| Pubmed | The mRNA-bound proteome and its global occupancy profile on protein-coding transcripts. | SMG1 CCT3 RRP1B ZC3H13 ANKHD1 DDX10 DDX50 UTP15 HELZ UTP20 DDX24 ROCK2 XRCC5 CEBPZ MACF1 PRKDC PUM1 CNOT1 | 2.01e-06 | 807 | 208 | 18 | 22681889 |
| Pubmed | ∆F508 CFTR interactome remodelling promotes rescue of cystic fibrosis. | MYH8 CLTCL1 UGGT1 DARS1 ACTN1 PGAM1 PGAM4 EIF3M IPO8 COPA KRT18 MYO1B XRCC5 NCAPH UBR3 PRKDC | 2.06e-06 | 647 | 208 | 16 | 26618866 |
| Pubmed | CCT3 RRP1B MYCBP2 MCM3 PSMD2 DARS1 AP2A2 NFKB2 EIF3M COPA DHX40 ECPAS XRCC5 INTS10 PELP1 GEMIN4 PRKDC CNOT1 | 2.08e-06 | 809 | 208 | 18 | 32129710 | |
| Pubmed | 2.09e-06 | 5 | 208 | 3 | 34555357 | ||
| Pubmed | 2.09e-06 | 5 | 208 | 3 | 31932854 | ||
| Pubmed | 2.39e-06 | 64 | 208 | 6 | 26511642 | ||
| Pubmed | RRP1B UGGT1 MCM3 ACTN1 AP2A1 AP2A2 UTP15 MRE11 COPA KRT18 NUP98 XRCC5 CWC22 THOC5 MACF1 PRKDC | 2.66e-06 | 660 | 208 | 16 | 32780723 | |
| Pubmed | CCT3 PDPK1 PSMD2 CEP78 COPA ECPAS MAPK14 FANCI PRKAA1 DZIP3 GEMIN4 PRKDC NBR1 | 2.66e-06 | 437 | 208 | 13 | 20562859 | |
| Pubmed | SGSM1 CUL9 PDE10A PGAM1 USP19 PGAM4 SLC4A8 RPS6KA4 DHX40 KLHL25 SLC4A10 NBR1 | 2.77e-06 | 371 | 208 | 12 | 15747579 | |
| Pubmed | A dual-activity topoisomerase complex regulates mRNA translation and turnover. | CLTCL1 MYO1E MYCBP2 MYO10 CUL9 ANKHD1 FOCAD AP2A1 KCNH2 NFKB2 WDR90 HSPG2 HECTD4 ADGRL1 KLHL25 MEGF8 MROH6 FANCI PRKDC WDFY3 PUM1 | 3.44e-06 | 1105 | 208 | 21 | 35748872 |
| Pubmed | DNAJB11 CCT3 RRP1B MYCBP2 UGGT1 PSMD2 ANKHD1 TBC1D4 AP2A1 DDX50 EIF3M ROCK2 CACNA2D1 COPA KRT18 MYO1B XRCC5 PELP1 MACF1 PRKDC IKBKB CNOT1 NBR1 | 3.63e-06 | 1297 | 208 | 23 | 33545068 | |
| Pubmed | LRRC31 inhibits DNA repair and sensitizes breast cancer brain metastasis to radiation therapy. | 3.92e-06 | 202 | 208 | 9 | 33005030 | |
| Pubmed | CHD3 and CHD4 form distinct NuRD complexes with different yet overlapping functionality. | RRP1B ZC3H13 MCM3 DDX10 DDX50 ZBTB5 DDX24 MRE11 KRT18 MYO1B XRCC5 PELP1 CEBPZ GEMIN4 PRKDC | 4.20e-06 | 605 | 208 | 15 | 28977666 |
| Pubmed | DNAJB11 PSMD2 ACTN1 USP32 ROCK2 COPA MYO1B RGS12 FANCI MACF1 PRKDC | 4.33e-06 | 322 | 208 | 11 | 26514267 | |
| Pubmed | DNAJB11 HK2 DARS1 ANKHD1 TBC1D4 AP2A1 COPA NUP98 XRCC5 CUL5 FANCI PRKDC PUM1 CNOT1 | 4.70e-06 | 534 | 208 | 14 | 35032548 | |
| Pubmed | 4.86e-06 | 156 | 208 | 8 | 32850835 | ||
| Pubmed | 4.86e-06 | 156 | 208 | 8 | 22952844 | ||
| Pubmed | An organelle-specific protein landscape identifies novel diseases and molecular mechanisms. | MYO1E RRP1B MYCBP2 TCP11L1 MCM3 ACTN1 TUBGCP4 TBC1D4 AP2A1 AP2A2 TBC1D1 HELZ DDX24 EIF3M CUL4B ROCK2 MRE11 IPO8 MYO19 TMEM120A DZIP3 CNOT1 EDRF1 | 4.90e-06 | 1321 | 208 | 23 | 27173435 |
| Pubmed | DNAJB11 HK2 CCT3 UGGT1 MCM3 PSMD2 ACTN1 COPA MYO1B MACF1 PRKDC | 5.01e-06 | 327 | 208 | 11 | 31409639 | |
| Pubmed | The Nse5/6-like SIMC1-SLF2 complex localizes SMC5/6 to viral replication centers. | RRP1B ZC3H13 MCM3 DDX10 DDX50 DDX24 CUL4B MRE11 KRT18 NUP98 XRCC5 CWC22 ORC2 TAF3 PELP1 CEBPZ FANCI PRKDC PUM1 | 5.31e-06 | 954 | 208 | 19 | 36373674 |
| Pubmed | 5.59e-06 | 113 | 208 | 7 | 30352685 | ||
| Pubmed | CCT3 ANKS1A CUL4B MRE11 NUP98 NCAPH TFAP2C ORC2 TAF3 PELP1 CEBPZ FANCI CNOT1 | 5.72e-06 | 469 | 208 | 13 | 27634302 | |
| Pubmed | DNAJB11 CCT3 UGGT1 MCM3 PSMD2 DDX24 COPA PELP1 CEBPZ PRKDC ARHGAP45 | 5.95e-06 | 333 | 208 | 11 | 36779763 | |
| Pubmed | KAP1 facilitates reinstatement of heterochromatin after DNA replication. | CCT3 BCAT1 MCM3 DARS1 ANKHD1 AP2A1 UTP15 UTP20 DDX24 MRE11 COPA NCAPH NUBP2 CEBPZ PRKDC CNOT1 | 6.00e-06 | 704 | 208 | 16 | 29955894 |
| Pubmed | Interactome analysis reveals that lncRNA HULC promotes aerobic glycolysis through LDHA and PKM2. | 6.14e-06 | 161 | 208 | 8 | 32572027 | |
| Pubmed | 6.26e-06 | 214 | 208 | 9 | 22199357 | ||
| Pubmed | Repression of rRNA transcription by PARIS contributes to Parkinson's disease. | 6.26e-06 | 272 | 208 | 10 | 25315684 | |
| Pubmed | 6.55e-06 | 44 | 208 | 5 | 26471122 | ||
| Pubmed | A multiprotein complex necessary for both transcription and DNA replication at the β-globin locus. | 6.87e-06 | 21 | 208 | 4 | 20808282 | |
| Pubmed | PTENα and PTENβ promote carcinogenesis through WDR5 and H3K4 trimethylation. | 7.00e-06 | 217 | 208 | 9 | 31685992 | |
| Pubmed | MYO1E RMI1 AP2A1 AP2A2 MRE11 COPA MYO1B XRCC5 PELP1 GEMIN4 PRKDC | 7.24e-06 | 340 | 208 | 11 | 24332808 | |
| Pubmed | CCT3 RRP1B DARS1 DDX10 AP2A1 DDX50 UTP15 UTP20 DDX24 XRCC5 PELP1 CEBPZ PRKDC | 7.83e-06 | 483 | 208 | 13 | 36912080 | |
| Pubmed | CLTCL1 MCM3 ACTN1 ANKHD1 FOCAD AP2A1 AP2A2 MYO1B NCAPH NUBP2 PELP1 CEBPZ | 7.83e-06 | 411 | 208 | 12 | 36652389 | |
| Pubmed | 9.37e-06 | 225 | 208 | 9 | 12168954 | ||
| Interaction | SIRT7 interactions | CCT3 RRP1B MYCBP2 ZC3H13 UGGT1 CUL9 PSMD2 ACTN1 ANKHD1 PGAM1 DDX10 UTP15 HELZ UTP20 DDX24 CUL4B MRE11 COPA NUP98 MYO1B ECPAS XRCC5 PELP1 CEBPZ FANCI GEMIN4 MACF1 PRKDC PUM1 CNOT1 | 7.17e-11 | 744 | 201 | 30 | int:SIRT7 |
| Interaction | EED interactions | DNAJB11 MAN1A1 HK2 CCT3 MYO1E RRP1B MYCBP2 ZC3H13 UGGT1 MCM3 PSMD2 DARS1 ACTN1 PGAM1 DDX10 AP2A1 DDX50 AP2A2 NFKB2 UTP20 DDX24 EIF3M CUL4B MRE11 HSPG2 RPS6KA4 COPA KRT18 MYO19 NUP98 MYO1B XRCC5 CWC22 CEBPZ PPM1F PRKAA1 MACF1 PRKDC CNOT1 NBR1 | 2.99e-09 | 1445 | 201 | 40 | int:EED |
| Interaction | BIRC3 interactions | CCT3 RRP1B UGGT1 MCM3 DARS1 PGAM1 USP19 DDX10 UBE4A AP2A1 DDX50 UTP15 UTP20 TDRD6 DDX24 EIF3M MRE11 IPO8 COPA NUP98 MYO1B XRCC5 CWC22 NMD3 PELP1 CEBPZ FANCI DNAJC11 DZIP3 GEMIN4 PRKDC IKBKB PUM1 CNOT1 NBR1 | 1.29e-07 | 1334 | 201 | 35 | int:BIRC3 |
| Interaction | EEF1AKMT3 interactions | CCT3 RPS6KA5 CUL9 ANKHD1 NFKB2 USP32 ARHGAP29 HELZ RGPD5 ANKS1A RPS6KA4 MYO1B MAPK14 GEMIN4 IKBKB EDRF1 | 8.21e-07 | 364 | 201 | 16 | int:EEF1AKMT3 |
| Interaction | C9orf78 interactions | UGGT1 PSMD2 TUBGCP4 UBE4A AP2A1 AP2A2 DDX24 CUL4B COPA TNPO2 MYO1B ECPAS CWC22 THOC5 NUBP2 INTS10 PELP1 FANCI PRKAA1 PUM1 CNOT1 | 1.11e-06 | 620 | 201 | 21 | int:C9orf78 |
| Interaction | POU5F1 interactions | HK2 CCT3 LRRK2 PSMD2 TUBGCP4 HELZ DDX24 BRWD1 CUL4B MRE11 HSPG2 IPO8 COPA ECPAS XRCC5 ORC2 MAPK14 FANCI PRKDC CNOT1 | 1.72e-06 | 584 | 201 | 20 | int:POU5F1 |
| Interaction | EGLN3 interactions | DNAJB11 HK2 CCT3 MYCBP2 UGGT1 MCM3 PSMD2 HIC2 ANKHD1 RMI1 TBC1D4 ZBTB5 HELZ FAM135A TARBP1 NOTCH3 MRE11 IPO8 COPA MYO1B ECPAS NCAPH NUBP2 TUBGCP6 FANCI DNAJC11 GEMIN4 PRKDC MAPK6 IKBKB PUM1 CNOT1 | 1.80e-06 | 1296 | 201 | 32 | int:EGLN3 |
| Interaction | BRCA1 interactions | DNAJB11 HK2 MAN2C1 CCT3 UGGT1 MCM3 PSMD2 DARS1 RMI1 AP2A1 DDX24 EIF3M CUL4B MRE11 RPS6KA4 COPA KRT18 RBL2 DHX40 ECPAS XRCC5 TFAP2C TRIM45 ORC2 FANCI DZIP3 TNKS PRKDC TNKS2 IKBKB CNOT1 | 2.40e-06 | 1249 | 201 | 31 | int:BRCA1 |
| Interaction | MEX3B interactions | ENPP6 SMG1 ANKHD1 CNOT8 AP2A1 HELZ TNPO2 DZIP3 PUM1 CNOT1 NBR1 EDRF1 | 2.48e-06 | 222 | 201 | 12 | int:MEX3B |
| Interaction | CIT interactions | CLTCL1 CCT3 MYO1E RRP1B ZC3H13 LRRK2 MCM3 PSMD2 DARS1 ACTN1 ADGRV1 DDX10 AP2A1 DDX50 AP2A2 UTP15 UTP20 TARBP1 EIF3M COPA TNPO2 PRSS56 NUP98 MYO1B ECPAS XRCC5 THOC5 ORC2 PELP1 CEBPZ FANCI SLC4A10 MACF1 PRKDC | 2.58e-06 | 1450 | 201 | 34 | int:CIT |
| Interaction | CCDC8 interactions | CCT3 RRP1B MYCBP2 UGGT1 CUL9 MCM3 PSMD2 DARS1 DDX50 UTP20 CACNA2D1 COPA KRT18 MYO1B XRCC5 MAPK14 PRKAA1 MACF1 PRKDC PUM1 CNOT1 | 2.71e-06 | 656 | 201 | 21 | int:CCDC8 |
| Interaction | EP300 interactions | CLTCL1 HK2 RPS6KA5 MCM3 PSMD2 HIC2 PGAM1 AP2A1 DDX50 AP2A2 ZBTB5 C1R DDX24 EIF3M CUL4B ROCK2 MRE11 COPA KRT18 NUP98 ABCC9 ECPAS XRCC5 TFAP2C NMD3 CUL5 ORC2 MAPK14 PELP1 PRKAA1 ROCK1 PRKDC PUM1 | 3.36e-06 | 1401 | 201 | 33 | int:EP300 |
| Interaction | UBXN6 interactions | UGGT1 PSMD2 ANKHD1 TBC1D4 USP32 HELZ RGPD5 ANKS1A RPS6KA4 COPA TUBGCP6 DNAJC11 PRKDC EDRF1 | 5.14e-06 | 325 | 201 | 14 | int:UBXN6 |
| Interaction | CYREN interactions | 5.21e-06 | 26 | 201 | 5 | int:CYREN | |
| Interaction | STIP1 interactions | HINT1 CCT3 LRRK2 MCM3 PSMD2 DARS1 ACTN1 USP19 TBC1D4 KCNH2 CUL4B MRE11 IPO8 COPA NUP98 ECPAS XRCC5 WDFY4 PELP1 FANCI GEMIN4 PRKDC MAPK6 PUM1 CNOT1 NBR1 | 8.43e-06 | 1006 | 201 | 26 | int:STIP1 |
| Interaction | TERF2 interactions | DNAJB11 MYO10 ZC3H13 ACTN1 PGAM1 AP2A2 TDRD6 DDX24 MRE11 DHX40 XRCC5 ORC2 MACF1 TNKS | 8.60e-06 | 340 | 201 | 14 | int:TERF2 |
| Interaction | G3BP1 interactions | CCT3 RRP1B MYCBP2 PDPK1 PSMD2 USP19 DDX50 HELZ EIF3M RASA1 COPA KRT18 TNPO2 DHX40 NUP98 CWC22 PDLIM4 PELP1 PRKAA1 MACF1 PUM1 CNOT1 NBR1 | 1.06e-05 | 835 | 201 | 23 | int:G3BP1 |
| Interaction | PRKY interactions | 1.16e-05 | 140 | 201 | 9 | int:PRKY | |
| Interaction | FOXQ1 interactions | 1.23e-05 | 141 | 201 | 9 | int:FOXQ1 | |
| Interaction | BAP1 interactions | DNAJB11 HINT1 CCT3 MYCBP2 TCP11L1 ZC3H13 UGGT1 MCM3 PSMD2 DARS1 ACTN1 ANKHD1 PGAM1 TBC1D4 AP2A1 AP2A2 CUL4B MRE11 COPA KRT18 TNPO2 MYO1B ECPAS XRCC5 NCAPH FANCI GEMIN4 MACF1 PRKDC CNOT1 | 1.81e-05 | 1314 | 201 | 30 | int:BAP1 |
| Interaction | HIF1AN interactions | CCT3 MCM3 ANKHD1 NFKB2 FAM135A NOTCH3 ANKS1A MYO1B TUBGCP6 DNAJC11 TNKS TNKS2 CNOT1 | 1.89e-05 | 317 | 201 | 13 | int:HIF1AN |
| Interaction | MNDA interactions | 1.99e-05 | 188 | 201 | 10 | int:MNDA | |
| Interaction | C3orf18 interactions | 2.02e-05 | 115 | 201 | 8 | int:C3orf18 | |
| Interaction | KCNA3 interactions | CCT3 LRRK2 MCM3 PSMD2 DARS1 PGAM1 TBC1D4 ARHGAP29 FAM135A ANKS1A ROCK2 MRE11 COPA MYO1B ECPAS XRCC5 FANCI GEMIN4 LRP6 MACF1 ROCK1 PRKDC CNOT1 | 2.08e-05 | 871 | 201 | 23 | int:KCNA3 |
| Interaction | KDF1 interactions | 2.39e-05 | 192 | 201 | 10 | int:KDF1 | |
| Interaction | AURKB interactions | CLTCL1 CCT3 MYO1E LRRK2 PSMD2 ADGRV1 TBC1D4 DDX50 DDX24 EIF3M RASA1 MYO1B XRCC5 NCAPH NUBP2 GEMIN4 MACF1 PRKDC MAPK6 PUM1 CNOT1 | 2.57e-05 | 761 | 201 | 21 | int:AURKB |
| Interaction | GPR17 interactions | FAM114A2 TUBGCP4 UBE4A UTP20 TARBP1 IPO8 TNPO2 ECPAS GEMIN4 UBR3 PRKDC WDFY3 | 2.87e-05 | 283 | 201 | 12 | int:GPR17 |
| Interaction | HSP90AB1 interactions | MAN1A1 CCT3 MYCBP2 UGGT1 LRRK2 DARS1 ACTN1 USP19 DDX24 BRWD1 CUL4B RPS6KA4 MYO19 WDFY4 CUL5 MAPK14 PRKAA1 PRKDC MAPK4 MAPK6 IKBKB MAPK13 NBR1 EDRF1 | 3.29e-05 | 960 | 201 | 24 | int:HSP90AB1 |
| Interaction | VCP interactions | DNAJB11 HINT1 CCT3 MYCBP2 BCAT1 MCM3 PSMD2 ACTN1 ANKHD1 RYR3 CNOT8 UBE4A AP2A2 NFKB2 DDX24 CUL4B MRE11 COPA TNPO2 PTPRU XRCC5 NCAPH NMD3 CUL5 VPS13D FANCI DNAJC11 PRKAA1 PRKDC MAPK13 NBR1 | 3.75e-05 | 1435 | 201 | 31 | int:VCP |
| Interaction | HERC2 interactions | MYCBP2 LRRK2 MCM3 PSMD2 USP19 RMI1 ZBTB5 EIF3M COPA HECTD4 RGS12 THOC5 PELP1 MACF1 MAPK6 CNOT1 | 4.75e-05 | 503 | 201 | 16 | int:HERC2 |
| Interaction | EEF2K interactions | 5.05e-05 | 66 | 201 | 6 | int:EEF2K | |
| Interaction | CALM1 interactions | PDE1A MYO1E MYCBP2 MYO10 LRRK2 PSMD2 PGAM1 TBC1D4 CEP78 TBC1D1 BRWD1 CUL4B RASA1 MYO19 MYO1B VPS13D MAPK14 NBR1 | 5.91e-05 | 626 | 201 | 18 | int:CALM1 |
| Interaction | NR2C2 interactions | CCT3 RRP1B ZC3H13 MCM3 PSMD2 DARS1 DDX10 AP2A1 DDX50 AP2A2 UTP15 HELZ DDX24 EIF3M CUL4B MRE11 COPA NUP98 XRCC5 NCAPH CWC22 NUBP2 NMD3 ORC2 TAF3 CEBPZ DNAJC11 PRKDC IKBKB PUM1 | 6.13e-05 | 1403 | 201 | 30 | int:NR2C2 |
| Interaction | NXF1 interactions | CLTCL1 MYO1E PSMD2 ANKHD1 DDX50 AP2A2 CEP78 TOMM40L NFKB2 HELZ DDX24 RGPD5 CUL4B RAD51D IPO8 COPA TNPO2 NUP98 KBTBD2 THOC5 CUL5 TUBGCP6 MEGF8 CEBPZ FANCI DZIP3 MACF1 ROCK1 WDFY3 | 7.12e-05 | 1345 | 201 | 29 | int:NXF1 |
| Interaction | LMBR1L interactions | MAN1A1 HK2 PSMD2 USP19 DDX10 AP2A1 CEP78 UTP20 TARBP1 COPA KRT18 NUP98 ECPAS NMD3 CEBPZ FANCI PPM1F DNAJC11 GEMIN4 LRP6 PRKDC PUM1 NBR1 | 7.41e-05 | 946 | 201 | 23 | int:LMBR1L |
| Interaction | MAPK4 interactions | 7.63e-05 | 71 | 201 | 6 | int:MAPK4 | |
| Interaction | MCM2 interactions | MYH8 CCT3 TCP11L1 MCM3 PSMD2 DARS1 ACTN1 AP2A1 AP2A2 RGPD5 CUL4B MRE11 HSPG2 KRT18 XRCC5 ORC2 TAF3 HMCN1 FANCI GNB5 PRKAA1 MACF1 PRKDC CNOT1 NBR1 | 7.90e-05 | 1081 | 201 | 25 | int:MCM2 |
| Interaction | P2RY10 interactions | 9.36e-05 | 106 | 201 | 7 | int:P2RY10 | |
| Interaction | BTRC interactions | HINT1 CLTCL1 CCT3 MYCBP2 MYO10 TUBGCP4 TBC1D4 NFKB2 IL17RA RASA1 XRCC5 CWC22 NLRP3 CUL5 TUBGCP6 MAPK14 MAPK6 IKBKB MAPK13 CNOT1 | 1.01e-04 | 775 | 201 | 20 | int:BTRC |
| Interaction | RPS6KA1 interactions | RPS6KA5 PDPK1 DDX50 AP2A2 IL17RA RPS6KA4 DHX40 PPM1F DNAJC11 MAPK13 | 1.02e-04 | 228 | 201 | 10 | int:RPS6KA1 |
| Interaction | IFI16 interactions | DNAJB11 MYO1E RRP1B PSMD2 PGAM1 DDX10 DDX50 AP2A2 UTP15 HELZ UTP20 DDX24 IPO8 COPA NUP98 XRCC5 PELP1 CEBPZ CNOT1 | 1.02e-04 | 714 | 201 | 19 | int:IFI16 |
| Interaction | FPR1 interactions | 1.16e-04 | 147 | 201 | 8 | int:FPR1 | |
| Interaction | HOXB7 interactions | 1.21e-04 | 26 | 201 | 4 | int:HOXB7 | |
| Interaction | CHMP4B interactions | CLTCL1 MYO1E MYCBP2 UGGT1 EFCAB13 MCM3 PSMD2 ACTN1 DDX50 UTP15 TARBP1 COPA MYO19 PRSS56 NUP98 MYO1B NUBP2 FANCI PRKDC | 1.29e-04 | 727 | 201 | 19 | int:CHMP4B |
| Interaction | P2RY6 interactions | UGGT1 MCM3 PSMD2 TUBGCP4 UBE4A SLC27A2 IPO8 COPA ECPAS NCAPH FANCI GEMIN4 PRKDC | 1.37e-04 | 385 | 201 | 13 | int:P2RY6 |
| Interaction | LGALS3BP interactions | CCT3 MYCBP2 UGGT1 CUL9 TUBGCP4 HELZ CUL4B HECTD4 CUL5 TUBGCP6 CNOT1 | 1.47e-04 | 286 | 201 | 11 | int:LGALS3BP |
| Interaction | CASD1 interactions | 1.52e-04 | 11 | 201 | 3 | int:CASD1 | |
| Interaction | DUSP2 interactions | 1.59e-04 | 81 | 201 | 6 | int:DUSP2 | |
| Interaction | MAP1LC3A interactions | CLTCL1 CCT3 PDPK1 AP2A1 AP2A2 TBC1D1 PELP1 PRKAA1 WDFY3 NBR1 | 1.60e-04 | 241 | 201 | 10 | int:MAP1LC3A |
| Interaction | FOXL1 interactions | 1.60e-04 | 196 | 201 | 9 | int:FOXL1 | |
| Interaction | HDAC11 interactions | 1.60e-04 | 154 | 201 | 8 | int:HDAC11 | |
| Interaction | AKAP1 interactions | DNAJB11 HK2 UGGT1 FAM114A2 ACTN1 HELZ UTP20 TARBP1 MYO19 NUBP2 VPS13D FANCI DNAJC11 DZIP3 PUM1 | 1.67e-04 | 503 | 201 | 15 | int:AKAP1 |
| Interaction | FOXI2 interactions | 1.83e-04 | 53 | 201 | 5 | int:FOXI2 | |
| Interaction | CCT8L2 interactions | 1.83e-04 | 157 | 201 | 8 | int:CCT8L2 | |
| Interaction | NRXN2 interactions | 2.01e-04 | 12 | 201 | 3 | int:NRXN2 | |
| Interaction | GTSF1 interactions | 2.01e-04 | 12 | 201 | 3 | int:GTSF1 | |
| Interaction | FBP1 interactions | MYO1E GIMAP2 MCM3 ACTN1 ANKHD1 NFKB2 CUL4B COPA KRT18 MYO1B XRCC5 PRKDC | 2.05e-04 | 348 | 201 | 12 | int:FBP1 |
| Interaction | HULC interactions | 2.17e-04 | 161 | 201 | 8 | int:HULC | |
| Interaction | GPBP1L1 interactions | 2.21e-04 | 86 | 201 | 6 | int:GPBP1L1 | |
| Interaction | LRRC31 interactions | 2.24e-04 | 205 | 201 | 9 | int:LRRC31 | |
| Interaction | TMEM41B interactions | 2.27e-04 | 162 | 201 | 8 | int:TMEM41B | |
| Interaction | MAVS interactions | USP19 UBE4A MYO19 ZDHHC4 NLRP3 SLC39A12 VPS13D TNKS TNKS2 IKBKB NBR1 | 2.36e-04 | 302 | 201 | 11 | int:MAVS |
| Interaction | FGD5 interactions | 2.41e-04 | 207 | 201 | 9 | int:FGD5 | |
| Interaction | OPALIN interactions | 2.59e-04 | 209 | 201 | 9 | int:OPALIN | |
| Interaction | UFL1 interactions | CCT3 RRP1B MCM3 PSMD2 HIC2 DARS1 AP2A1 DDX50 CEP78 PGAM4 DDX24 MRE11 COPA DHX40 MYO1B ECPAS XRCC5 PELP1 DNAJC11 GEMIN4 ROCK1 PRKDC PUM1 | 2.61e-04 | 1031 | 201 | 23 | int:UFL1 |
| Interaction | HSPB1 interactions | LRRK2 ACTN1 CEP78 TBC1D1 DDX24 EIF3M RASA1 KRT18 ECPAS XRCC5 THOC5 MAPK14 DNAJC11 GEMIN4 PRKDC MAPK6 IKBKB PUM1 | 2.72e-04 | 708 | 201 | 18 | int:HSPB1 |
| Interaction | MBP interactions | 2.74e-04 | 126 | 201 | 7 | int:MBP | |
| Interaction | OBSL1 interactions | CCT3 RRP1B CUL9 MCM3 PSMD2 ACTN1 DDX10 AP2A1 DDX50 UTP20 MRE11 COPA KRT18 NUP98 XRCC5 MAPK14 PELP1 CEBPZ GEMIN4 MACF1 PRKDC | 2.78e-04 | 902 | 201 | 21 | int:OBSL1 |
| Interaction | OCIAD1 interactions | SGSM1 CLTCL1 HK2 FAM114A2 UTP20 DDX24 TARBP1 MYO19 NUP98 NCAPH VPS13D DNAJC11 NBR1 | 3.12e-04 | 419 | 201 | 13 | int:OCIAD1 |
| Interaction | ITGB3 interactions | 3.14e-04 | 170 | 201 | 8 | int:ITGB3 | |
| Interaction | CUL7 interactions | DNAJB11 CCT3 RRP1B CUL9 PSMD2 DARS1 ACTN1 DDX50 EIF3M MRE11 COPA KRT18 NUP98 MYO1B XRCC5 MAPK14 PELP1 MACF1 PRKDC MAPK6 | 3.16e-04 | 845 | 201 | 20 | int:CUL7 |
| Interaction | TACSTD2 interactions | 3.17e-04 | 129 | 201 | 7 | int:TACSTD2 | |
| Interaction | ZC3H7A interactions | 3.19e-04 | 215 | 201 | 9 | int:ZC3H7A | |
| Interaction | TOP3B interactions | CLTCL1 MYO1E MYCBP2 MYO10 CUL9 DARS1 ACTN1 ANKHD1 FOCAD RMI1 AP2A1 KCNH2 NFKB2 HELZ WDR90 HSPG2 HECTD4 ADGRL1 MYO1B XRCC5 KLHL25 MEGF8 MROH6 PELP1 FANCI PRKDC WDFY3 PUM1 CNOT1 | 3.25e-04 | 1470 | 201 | 29 | int:TOP3B |
| Interaction | USP11 interactions | CCT3 MYCBP2 MCM3 CNOT8 AP2A1 AP2A2 CUL4B MRE11 COPA DHX40 MYO1B XRCC5 MAPK14 PELP1 MAPK6 | 3.49e-04 | 539 | 201 | 15 | int:USP11 |
| Interaction | PAXX interactions | 3.52e-04 | 34 | 201 | 4 | int:PAXX | |
| Interaction | HSP90AA1 interactions | SMG1 HK2 RPS6KA5 PDPK1 LRRK2 MCM3 ACTN1 KLHL32 USP19 KCNH2 DDX24 BRWD1 CUL4B MRE11 HSPG2 RPS6KA4 NLRP3 CUL5 MAPK14 KLHL25 PRKAA1 PRKDC MAPK4 IKBKB MAPK13 EDRF1 | 3.58e-04 | 1263 | 201 | 26 | int:HSP90AA1 |
| Interaction | EIF4EBP1 interactions | 3.59e-04 | 94 | 201 | 6 | int:EIF4EBP1 | |
| Interaction | GYPA interactions | 3.68e-04 | 174 | 201 | 8 | int:GYPA | |
| Interaction | SCN2B interactions | 3.80e-04 | 95 | 201 | 6 | int:SCN2B | |
| Interaction | SOST interactions | 3.95e-04 | 35 | 201 | 4 | int:SOST | |
| Interaction | PRXL2B interactions | 4.07e-04 | 15 | 201 | 3 | int:PRXL2B | |
| Interaction | PTEN interactions | MAN1A1 CCT3 UGGT1 MCM3 PSMD2 RYR3 DDX50 NFKB2 DDX24 CUL4B COPA NUP98 MYO1B XRCC5 TCL1B PELP1 GEMIN4 ROCK1 TNKS PRKDC TNKS2 | 4.11e-04 | 929 | 201 | 21 | int:PTEN |
| Interaction | HDAC6 interactions | CCT3 MYO1E MYO10 LRRK2 MCM3 PSMD2 ACTN1 PGAM1 AP2A1 AP2A2 UTP15 TDRD6 CUL4B MRE11 COPA KRT18 MYO1B XRCC5 WDFY4 NLRP3 PRKDC | 4.11e-04 | 929 | 201 | 21 | int:HDAC6 |
| Interaction | USP14 interactions | RRP1B PSMD2 DARS1 ACTN1 EIF3M RGPD5 MRE11 COPA MYO1B XRCC5 NLRP3 MACF1 PRKDC CNOT1 | 4.15e-04 | 489 | 201 | 14 | int:USP14 |
| Interaction | FOXB1 interactions | 4.17e-04 | 135 | 201 | 7 | int:FOXB1 | |
| Interaction | CNOT2 interactions | 4.28e-04 | 178 | 201 | 8 | int:CNOT2 | |
| Interaction | BTG3 interactions | 4.49e-04 | 98 | 201 | 6 | int:BTG3 | |
| Interaction | GRM2 interactions | DNAJB11 CCT3 UGGT1 MCM3 PSMD2 DDX24 COPA RGS12 PELP1 CEBPZ PRKDC ARHGAP45 | 4.64e-04 | 381 | 201 | 12 | int:GRM2 |
| Interaction | TNIP1 interactions | DNAJB11 CCT3 MYO1E RRP1B MYO10 MCM3 PSMD2 DARS1 ACTN1 DDX10 AP2A1 DDX50 AP2A2 UTP15 UTP20 RPS6KA4 COPA KRT18 MYO1B XRCC5 CEBPZ GEMIN4 PRKDC IKBKB NBR1 | 4.82e-04 | 1217 | 201 | 25 | int:TNIP1 |
| Interaction | UNC45A interactions | 4.89e-04 | 228 | 201 | 9 | int:UNC45A | |
| Interaction | GRK5 interactions | 4.96e-04 | 182 | 201 | 8 | int:GRK5 | |
| Interaction | PSMD8 interactions | 4.96e-04 | 182 | 201 | 8 | int:PSMD8 | |
| Interaction | MKS1 interactions | 4.97e-04 | 139 | 201 | 7 | int:MKS1 | |
| Interaction | NPTN interactions | SMG1 CLTCL1 FOCAD UTP20 TARBP1 RPS6KA4 IPO8 TNPO2 ECPAS GEMIN4 | 4.98e-04 | 278 | 201 | 10 | int:NPTN |
| Interaction | AGO1 interactions | 5.14e-04 | 183 | 201 | 8 | int:AGO1 | |
| Interaction | TNRC6A interactions | 5.27e-04 | 280 | 201 | 10 | int:TNRC6A | |
| Interaction | WDFY4 interactions | 5.42e-04 | 141 | 201 | 7 | int:WDFY4 | |
| Interaction | UBC interactions | PDPK1 PSMD2 ACTN1 USP19 RMI1 AP2A1 AP2A2 USP32 ARHGAP29 HECTD4 CUL5 IKBKB NBR1 | 5.63e-04 | 446 | 201 | 13 | int:UBC |
| Interaction | NOS2 interactions | 5.72e-04 | 186 | 201 | 8 | int:NOS2 | |
| GeneFamily | Mitogen-activated protein kinases | 2.83e-06 | 13 | 147 | 4 | 651 | |
| GeneFamily | Cullins | 2.86e-05 | 8 | 147 | 3 | 1032 | |
| GeneFamily | Bisphosphoglycerate phosphatases | 3.90e-04 | 4 | 147 | 2 | 1082 | |
| Coexpression | NAKAYA_PLASMACYTOID_DENDRITIC_CELL_FLUMIST_AGE_18_50YO_7DY_UP | SMG1 RRP1B PSMD2 HIC2 DARS1 TUBGCP4 ANKHD1 RYR3 UBE4A TBC1D4 TBC1D1 EIF3M CUL4B RPS6KA4 SLC11A2 RASA1 RBL2 NUP98 ECPAS XRCC5 CUL5 HIPK3 MAPK14 FANCI DZIP3 MACF1 ROCK1 PRKDC IKBKB PUM1 CNOT1 EDRF1 | 1.92e-09 | 1215 | 206 | 32 | M41122 |
| Coexpression | GSE40493_BCL6_KO_VS_WT_TREG_UP | SMG1 CCT3 RRP1B UTP15 TBC1D1 DDX24 ROCK2 THOC5 NLRP3 VPS13D DNAJC11 TNKS2 | 1.75e-08 | 177 | 206 | 12 | M9401 |
| Coexpression | GRYDER_PAX3FOXO1_ENHANCERS_IN_TADS | RRP1B ZC3H13 BCAT1 SLC24A3 MCM3 DARS1 DDX10 RMI1 TBC1D1 ARHGAP29 CDON ANKS1A HSPG2 COPA RBL2 TRIM45 NSUN6 CEBPZ GNB5 PTAR1 UBR3 WDFY3 MAPK6 TNKS2 | 1.49e-06 | 1009 | 206 | 24 | M157 |
| Coexpression | DIAZ_CHRONIC_MYELOGENOUS_LEUKEMIA_UP | HK2 ATP7B CCT3 UGGT1 BCAT1 MCM3 PSMD2 DARS1 TUBGCP4 CNOT8 DDX10 UBE4A KCNH2 EIF3M SLC27A2 CUL4B MRE11 HSPG2 RASA1 COPA NUP98 XRCC5 NMD3 CUL5 ORC2 GEMIN4 PRKDC PUM1 NBR1 | 1.79e-06 | 1399 | 206 | 29 | M535 |
| Coexpression | GSE21063_3H_VS_16H_ANTI_IGM_STIM_BCELL_DN | 3.89e-06 | 197 | 206 | 10 | M8271 | |
| Coexpression | DACOSTA_UV_RESPONSE_VIA_ERCC3_DN | MYCBP2 MYO10 DDX10 ARHGAP29 FGF5 HELZ UTP20 ANKS1A ROCK2 SLC11A2 RASA1 NUP98 MYO1B ORC2 MAPK14 MACF1 ROCK1 TNKS WDFY3 MAPK6 PUM1 | 4.37e-06 | 856 | 206 | 21 | M4500 |
| Coexpression | PUJANA_ATM_PCC_NETWORK | HK2 RRP1B CUL9 BCAT1 DARS1 USP19 CNOT8 DDX10 TARBP1 EIF3M RAD51D MRE11 PCDHA12 NLRP3 CUL5 HIPK3 INTS10 PELP1 CEBPZ FANCI TGDS ROCK1 TNKS PRKDC IKBKB CNOT1 NBR1 LRIT1 | 5.00e-06 | 1394 | 206 | 28 | M9585 |
| Coexpression | GSE37605_FOXP3_FUSION_GFP_VS_IRES_GFP_TREG_C57BL6_DN | 1.12e-05 | 176 | 206 | 9 | M8790 | |
| Coexpression | GSE40273_XBP1_KO_VS_WT_TREG_DN | 2.98e-05 | 199 | 206 | 9 | M9124 | |
| Coexpression | GSE17721_CTRL_VS_GARDIQUIMOD_8H_BMDC_DN | 3.10e-05 | 200 | 206 | 9 | M3790 | |
| Coexpression | GSE360_L_MAJOR_VS_B_MALAYI_LOW_DOSE_DC_DN | 3.10e-05 | 200 | 206 | 9 | M5212 | |
| Coexpression | PUJANA_CHEK2_PCC_NETWORK | HK2 CCT3 RRP1B BCAT1 MCM3 DARS1 DDX10 UTP20 EIF3M MRE11 XRCC5 ZNF35 PELP1 CEBPZ FANCI TGDS PRKDC CNOT1 | 3.51e-05 | 761 | 206 | 18 | M11961 |
| Coexpression | DACOSTA_UV_RESPONSE_VIA_ERCC3_COMMON_DN | MYCBP2 MYO10 ARHGAP29 FGF5 HELZ ANKS1A ROCK2 RASA1 NUP98 MYO1B ORC2 MAPK6 PUM1 | 8.83e-05 | 466 | 206 | 13 | M13522 |
| CoexpressionAtlas | dev gonad_e12.5_F_GermCellOvary_Oct_top-relative-expression-ranked_1000 | RPS6KA5 RRP1B MCM3 PSMD2 DARS1 DDX10 HELZ UTP20 FAM135A SLC27A2 BRWD1 CUL4B MRE11 XRCC5 TFAP2C NMD3 ORC2 FANCI DZIP3 PRKDC EDRF1 | 4.62e-05 | 822 | 204 | 21 | gudmap_dev gonad_e12.5_F_GermCellOvary_Oct_1000 |
| CoexpressionAtlas | DevelopingKidney_e15.5_cortic collect duct_emap-28132_top-relative-expression-ranked_1000 | SMG1 ABCA3 MYCBP2 MYO10 TUBGCP4 TBC1D1 FAM135A SLC27A2 BRWD1 CUL4B CACNA2D1 RASA1 KRT18 GSDMC CUL5 PTAR1 DZIP3 UBR3 MAPK4 TNKS2 | 6.04e-05 | 774 | 204 | 20 | gudmap_developingKidney_e15.5_cortic collect duct_1000 |
| CoexpressionAtlas | facebase_RNAseq_e10.5_Emin_LatNas_2500 | HK2 RRP1B MYO10 ZC3H13 BCAT1 HIC2 ADGRV1 DDX10 UTP20 PHF21B SLC27A2 BRWD1 CUL4B ROCK2 SLC4A8 IPO8 RASA1 DHX40 NCAPH CWC22 TFAP2C NMD3 CUL5 ORC2 FEZ1 DZIP3 MACF1 ROCK1 MAPK4 MAPK6 | 6.41e-05 | 1459 | 204 | 30 | facebase_RNAseq_e10.5_Emin_LatNas_2500 |
| CoexpressionAtlas | DevelopingKidney_e15.5_cortic collect duct_emap-28132_k-means-cluster#4_top-relative-expression-ranked_1000 | SMG1 MYCBP2 MYO10 TUBGCP4 FAM135A CUL4B CACNA2D1 RASA1 CUL5 PTAR1 DZIP3 UBR3 TNKS2 | 7.32e-05 | 375 | 204 | 13 | gudmap_developingKidney_e15.5_cortic collect duct_1000_k4 |
| CoexpressionAtlas | facebase_RNAseq_e9.5_MandArch_2500_K3 | RRP1B PDPK1 HIC2 ACTN1 PGAM1 TBC1D4 CEP78 UTP15 HELZ UTP20 MRE11 SLC11A2 PPFIBP2 MYO19 ECPAS SLC45A4 PDLIM4 NMD3 CUL5 TUBGCP6 ORC2 PELP1 SLC26A7 DNAJC11 PTAR1 GEMIN4 ARHGAP45 | 7.71e-05 | 1259 | 204 | 27 | facebase_RNAseq_e9.5_MandArch_2500_K3 |
| CoexpressionAtlas | FacebaseRNAseq_e10.5_Maxillary Arch_top-relative-expression-ranked_1000_k-means-cluster#3 | UBE4A DDX50 FGF5 FAM135A BRWD1 ROCK2 PRRX1 ABCC9 ECPAS NCAPH TAF3 UBR3 MACF1 ROCK1 | 7.95e-05 | 432 | 204 | 14 | Facebase_RNAseq_e10.5_Maxillary Arch_1000_K3 |
| CoexpressionAtlas | dev gonad_e12.5_M_GermCellTestis_Oct_top-relative-expression-ranked_1000 | RPS6KA5 RRP1B MCM3 DARS1 DDX10 CEP78 UTP15 UTP20 SLC27A2 CUL4B MRE11 XRCC5 CWC22 TFAP2C NMD3 ORC2 CEBPZ FANCI PRKDC MAPK13 | 8.70e-05 | 795 | 204 | 20 | gudmap_dev gonad_e12.5_M_GermCellTestis_Oct_1000 |
| CoexpressionAtlas | DevelopingLowerUrinaryTract_P1_bladder_J_emap-30374_k-means-cluster#1_top-relative-expression-ranked_1000 | 9.90e-05 | 149 | 204 | 8 | gudmap_developingLowerUrinaryTract_P1_bladder_J_1000_k1 | |
| CoexpressionAtlas | dev gonad_e13.5_F_MeioticGermCell_Oct_top-relative-expression-ranked_1000 | SMG1 RPS6KA5 PSMD2 DARS1 TUBGCP4 DDX10 USP32 HELZ FAM135A SLC27A2 BRWD1 CUL4B MRE11 NMD3 ORC2 FANCI DZIP3 PRKDC CFAP61 EDRF1 | 1.32e-04 | 820 | 204 | 20 | gudmap_dev gonad_e13.5_F_MeioticGermCell_Oct_1000 |
| ToppCell | facs-Heart-LV-3m-Mesenchymal-valve_cell|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | SLC24A3 TBC1D1 PLCL1 NOTCH3 SLC4A8 PPFIBP2 ABCC9 MYO1B ADAP2 | 1.92e-07 | 181 | 208 | 9 | 06174ce9240c9261c0f51a1b0d875335d60722e5 |
| ToppCell | facs-Heart-LV-3m-Mesenchymal-valve_cell|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | SLC24A3 TBC1D1 PLCL1 NOTCH3 SLC4A8 PPFIBP2 ABCC9 MYO1B ADAP2 | 1.92e-07 | 181 | 208 | 9 | 1db1eb7d330a7e5090994007ae287e11f0a74450 |
| ToppCell | facs-Heart-LA-3m-Mesenchymal-valve_cell|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | SLC24A3 TBC1D1 PLCL1 NOTCH3 SLC4A8 PPFIBP2 ABCC9 MYO1B ADAP2 | 2.53e-07 | 187 | 208 | 9 | a12f383b02b07af32cc53a154685df8dba8fbd3f |
| ToppCell | facs-Heart-LA-3m-Mesenchymal-valve_cell|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | SLC24A3 TBC1D1 PLCL1 NOTCH3 SLC4A8 PPFIBP2 ABCC9 MYO1B ADAP2 | 2.53e-07 | 187 | 208 | 9 | c40c152fa14e6afc9188549534b64ccbaded56b3 |
| ToppCell | AT2_cells-SSc-ILD_01|World / lung cells shred on cell class, cell subclass, sample id | 3.92e-07 | 197 | 208 | 9 | 42e49a8ce3118db6c2fd620d70c480b75143c828 | |
| ToppCell | LPS_only-Epithelial_alveolar-AT_2-Differentiating_AT2|LPS_only / Treatment groups by lineage, cell group, cell type | 3.92e-07 | 197 | 208 | 9 | 1a1bee8da6e04b65935c40373eaee4d6c046d9a1 | |
| ToppCell | facs-Limb_Muscle-forelimb_and_hindlimb-18m-Lymphocytic-T_cell|Limb_Muscle / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.29e-06 | 168 | 208 | 8 | 182f08106ac65ea501e2fb9139d3b44b7c4662c9 | |
| ToppCell | BAL-Control-cDC_6|Control / Compartment, Disease Groups and Clusters | 1.29e-06 | 168 | 208 | 8 | 65ec473cff748b334c0a66e33bc34a8465fe7631 | |
| ToppCell | facs-Heart-LV-18m-Mesenchymal-valve_cell|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.60e-06 | 173 | 208 | 8 | d78397e65e997ddb995111a810f0e2a4f67d0765 | |
| ToppCell | facs-Heart-LV-18m-Mesenchymal-valve_cell|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.60e-06 | 173 | 208 | 8 | 3c852ffe22f4a5b632463086b08c669310684e80 | |
| ToppCell | facs-Heart-RA-18m-Mesenchymal-valve_cell|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.44e-06 | 183 | 208 | 8 | 2f0dcc65ad4d90ef946919b4462280fdd20c5ea0 | |
| ToppCell | facs-Heart-RA-18m-Mesenchymal-valve_cell|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.44e-06 | 183 | 208 | 8 | 0f02136359787bd78146617990968baa47a65d86 | |
| ToppCell | facs-Heart-RV-3m-Mesenchymal-valve_cell|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.54e-06 | 184 | 208 | 8 | 9c20b50f8d6ac689d41d5440c835f9db8d04758b | |
| ToppCell | facs-Heart-RV-3m-Mesenchymal-valve_cell|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.54e-06 | 184 | 208 | 8 | 31dbe6119a3bcd266ae5e9b340c853d9ff680dce | |
| ToppCell | droplet-Heart-nan-18m-Mesenchymal-smooth_muscle_cell|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.86e-06 | 187 | 208 | 8 | 2591fe1552cd10925ad1d8d1f062a057ce6bdad9 | |
| ToppCell | droplet-Heart-nan-18m-Mesenchymal-smooth_muscle_cell|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.86e-06 | 187 | 208 | 8 | 59313a47a6012b2413d7d3673bb05fb7e49fd88f | |
| ToppCell | LA-13._Vascular_Smooth_Muscle|LA / Chamber and Cluster_Paper | 2.98e-06 | 188 | 208 | 8 | 34e1b074a3995aa46ab194eb45115d76d1a5514d | |
| ToppCell | PBMC-Mild-cDC_12|Mild / Compartment, Disease Groups and Clusters | 3.10e-06 | 189 | 208 | 8 | 946c95d2ecc36b241f58e8c4ad6455fe47c762fa | |
| ToppCell | LA-13._Vascular_Smooth_Muscle|World / Chamber and Cluster_Paper | 3.10e-06 | 189 | 208 | 8 | 6b3e88751b95fc2173f2c3d5061ed632d0c5f01c | |
| ToppCell | Smart-seq2-spleen_(Smart-seq2)-myeloid-myeloid_granulocytic|spleen_(Smart-seq2) / Per Platform+tissue_group, by lineage_subgroup, cell_group, cell_type | 3.90e-06 | 195 | 208 | 8 | 19853c654ac64b3ae3bc99841c6cb29c8aaba85c | |
| ToppCell | Smart-seq2-spleen_(Smart-seq2)-myeloid-myeloid_granulocytic-neutrophil|spleen_(Smart-seq2) / Per Platform+tissue_group, by lineage_subgroup, cell_group, cell_type | 3.90e-06 | 195 | 208 | 8 | d3755929ebbbf5e3afde44281e9056ddb614a291 | |
| ToppCell | PND28-Mesenchymal-Mesenchymal_myocytic-Myofibroblast_vascular-VSMC|PND28 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 3.90e-06 | 195 | 208 | 8 | 56e7cd980f8fc2dae842e6a7bd919d4b41cebbbb | |
| ToppCell | PND28-Mesenchymal-Mesenchymal_myocytic-Myofibroblast_vascular-VSMC-VSMC_mature|PND28 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 3.90e-06 | 195 | 208 | 8 | a28a504c69bc4dda7de023e1b4ea4f62390b158e | |
| ToppCell | primary_visual_cortex|World / Per Region, Lineage, Cell class, Cell type, Cell subtype | 4.57e-06 | 141 | 208 | 7 | 605d7b28e99c943f64b4095855a6f9f70e92cb09 | |
| ToppCell | 356C-Myeloid-Macrophage-FABP4+_Macrophage|Macrophage / Donor, Lineage, Cell class and subclass (all cells) | 1.13e-05 | 162 | 208 | 7 | 2259e9536147e9cdee772e3a30ba7d104573262c | |
| ToppCell | renal_papilla_nuclei-Adult_normal_reference-Epithelial-Intermediate_tubule_epithelial_cell-kidney_loop_of_Henle_thin_descending_limb_epithelial_cell-Descending_Thin_Limb_Cell_Type_2|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 1.23e-05 | 164 | 208 | 7 | 382e42701779d12a7948690b3be72d06dd75c8b4 | |
| ToppCell | 356C-Myeloid-Macrophage-FABP4+_Macrophage|Myeloid / Donor, Lineage, Cell class and subclass (all cells) | 1.33e-05 | 166 | 208 | 7 | 89e2b8453180983533faccb4275867861876d7ee | |
| ToppCell | COVID-19-lung-MAST|lung / Disease (COVID-19 only), tissue and cell type | 1.55e-05 | 170 | 208 | 7 | e90f18e5462381b38e918442b38b1c8105291908 | |
| ToppCell | renal_medulla_nuclei-Hypertensive_with+without-CKD-Epithelial-Distal_tubule_epithelial_cell-kidney_loop_of_Henle_thick_ascending_limb_epithelial_cell-Medullary_Thick_Ascending_Limb_Cell|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 1.67e-05 | 172 | 208 | 7 | 1565f38266891c3acf49778838de134c5dee5460 | |
| ToppCell | NS-critical-d_16-33-Epithelial-Basal|d_16-33 / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined) | 1.74e-05 | 173 | 208 | 7 | 3d3afc9ab234eaabf5b9bff455406231cd54ded6 | |
| ToppCell | renal_cortex_nuclei-Hypertensive_with+without-CKD-Epithelial-Distal_tubule_epithelial_cell-kidney_loop_of_Henle_thick_ascending_limb_epithelial_cell-Medullary_Thick_Ascending_Limb_Cell|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 1.87e-05 | 175 | 208 | 7 | e5467dacf81f1f913b1719931cf1a7331434a7e7 | |
| ToppCell | 356C-Myeloid-Macrophage-FABP4+_Macrophage_3|Myeloid / Donor, Lineage, Cell class and subclass (all cells) | 2.01e-05 | 177 | 208 | 7 | 3d955ea938a1d2fb1b6d68d4997fd454bd632dfc | |
| ToppCell | renal_cortex_nuclei-Adult_normal_reference-Epithelial-Distal_tubule_epithelial_cell-kidney_loop_of_Henle_thick_ascending_limb_epithelial_cell-Medullary_Thick_Ascending_Limb_Cell|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 2.09e-05 | 178 | 208 | 7 | 4df6218b20c2f076c22346d23260964cc0d73e65 | |
| ToppCell | P28-Mesenchymal-mesenchymal_fibroblast-mesothelial_cell_of_visceral_pleura|P28 / developmental_time, Lineage, Cell group, Cell type, Cell type_cellcyc-phase | 2.09e-05 | 178 | 208 | 7 | 1e05bc26591fea16e29bcfc5f538dda1dc427f05 | |
| ToppCell | 343B-Lymphocytic-CD4_T-cell-CD4+_Effector_T_cell-2|343B / Donor, Lineage, Cell class and subclass (all cells) | 2.09e-05 | 178 | 208 | 7 | 5289ac61637224ae70ffbc2d164d73116f10af40 | |
| ToppCell | Anterior_Cingulate_gyrus_(CgG)-Neuronal-Glutamatergic_Excit-Glut_E_(THEMIS)-Glut_IT_L5/L6_Car3_THEMIS|Anterior_Cingulate_gyrus_(CgG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 2.16e-05 | 179 | 208 | 7 | 820289f14ecf165758529c236bb220bb1a744f02 | |
| ToppCell | Anterior_Cingulate_gyrus_(CgG)-Neuronal-Glutamatergic_Excit-Glut_E_(THEMIS)-Glut_IT_L5/L6_Car3_THEMIS-Exc_L5-6_THEMIS_GPR21|Anterior_Cingulate_gyrus_(CgG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 2.16e-05 | 179 | 208 | 7 | e5f781d35449628a7f356d71e26231dd63482eec | |
| ToppCell | PND28-Immune-Immune_Myeloid-DC-cDC1-cDC1_prolif|PND28 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 2.16e-05 | 179 | 208 | 7 | 9dea57494d59abd6e8abf34e31faf53462ea0fa0 | |
| ToppCell | renal_medulla_nuclei-Hypertensive_with+without-CKD-Epithelial-Distal_tubule_epithelial_cell-kidney_loop_of_Henle_thick_ascending_limb_epithelial_cell|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 2.24e-05 | 180 | 208 | 7 | a17dbe03597b81e7a1fe2bf2d23e59e55c615a2a | |
| ToppCell | renal_medulla_nuclei-Hypertensive_with+without-CKD-Epithelial-Distal_tubule_epithelial_cell|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 2.24e-05 | 180 | 208 | 7 | eee71184ebed2694d3e60f579a44b3cf7dd2cd35 | |
| ToppCell | CV-Severe-4|Severe / Virus stimulation, Condition and Cluster | 2.24e-05 | 180 | 208 | 7 | cf84a01e6a33e5d27ad7be1d9069a0370b5116d1 | |
| ToppCell | renal_cortex_nuclei-Adult_normal_reference-Epithelial-Collecting_tubule_epithelial_cell-kidney_collecting_duct_intercalated_cell|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 2.32e-05 | 181 | 208 | 7 | 30729f0364f719c044712a51453e22dc2c1a232b | |
| ToppCell | COVID-19-Heart-Pericyte|COVID-19 / Disease (COVID-19 only), tissue and cell type | 2.32e-05 | 181 | 208 | 7 | 33cac65ed1ea5e7bd72250495df4f850b143d5aa | |
| ToppCell | CV-Severe-4|CV / Virus stimulation, Condition and Cluster | 2.41e-05 | 182 | 208 | 7 | c19bbc43d97c426aec37414f46f667a19b62a257 | |
| ToppCell | renal_medulla_nuclei-CKD+DKD_normotensive-Epithelial-Distal_tubule_epithelial_cell-kidney_loop_of_Henle_thick_ascending_limb_epithelial_cell|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 2.49e-05 | 183 | 208 | 7 | 31ab55d5f3639f5964541d5eae23044dbda3356e | |
| ToppCell | E15.5-Mesenchymal-mesenchymal_fibroblast-mesothelial_cell_of_visceral_pleura|E15.5 / developmental_time, Lineage, Cell group, Cell type, Cell type_cellcyc-phase | 2.49e-05 | 183 | 208 | 7 | 274f274cf60daa30d6a4cd603a3af7823bfb8016 | |
| ToppCell | LPS-antiTNF-Stromal_mesenchymal-Lung_smooth_muscle-Pericyte_2|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 2.58e-05 | 184 | 208 | 7 | 689a8af81a79a4bb3123cfa01958c953eab5de98 | |
| ToppCell | CV-Moderate-4|CV / Virus stimulation, Condition and Cluster | 2.58e-05 | 184 | 208 | 7 | 90f5b447064743246b09a6c47bf561efafa15e1f | |
| ToppCell | E17.5-Mesenchymal-mesenchymal_fibroblast-mesothelial_cell_of_visceral_pleura|E17.5 / developmental_time, Lineage, Cell group, Cell type, Cell type_cellcyc-phase | 2.58e-05 | 184 | 208 | 7 | 607b55022de21ddb6a2d75e085df76df7abf6624 | |
| ToppCell | MS-matDC|MS / Condition, Cell_class and T cell subcluster | 2.67e-05 | 185 | 208 | 7 | 46bd897349598d85e718e25f9a045d2247723c61 | |
| ToppCell | facs-Brain_Non-Myeloid-Striatum-24m-Mesenchymal-brain_pericyte|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.67e-05 | 185 | 208 | 7 | 38486b69c48dc5e1c4e1488208fa8954a973eccb | |
| ToppCell | MS-matDC-|MS / Condition, Cell_class and T cell subcluster | 2.67e-05 | 185 | 208 | 7 | 9fbe70d3a7b106fb31e13b7f95029785f28ca6f4 | |
| ToppCell | CV-Moderate-4|Moderate / Virus stimulation, Condition and Cluster | 2.67e-05 | 185 | 208 | 7 | 4a3ce0c603c2ffe11f0f00775b6af4f6d9a6070a | |
| ToppCell | renal_medulla_nuclei-CKD+DKD_normotensive-Epithelial-Distal_tubule_epithelial_cell|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 2.67e-05 | 185 | 208 | 7 | 898a093757f86be3e18d2ef1f16a71f50ef81dc3 | |
| ToppCell | facs-Brain_Non-Myeloid-Striatum-24m-Mesenchymal-Pericyte|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.67e-05 | 185 | 208 | 7 | 3c28b5ceba3cfdb6f7e32d5b42e03b6a81a7a658 | |
| ToppCell | droplet-Lung-21m-Endothelial-arterial_endothelial-pulmonary_artery_endothelial_cell-pulmonary_artery_endothelial_cell_l27|21m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 2.77e-05 | 186 | 208 | 7 | c116cc9f41971622264434ebe29d18e719b0ae19 | |
| ToppCell | LPS-IL1RA+antiTNF-Stromal_mesenchymal-Lung_smooth_muscle-Pericyte_3|LPS-IL1RA+antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 2.77e-05 | 186 | 208 | 7 | a95744b8649096bd7cfc3591a02841fa411085b3 | |
| ToppCell | TCGA-Pancreas-Primary_Tumor-Pancreatic_Adenocarcinoma-Ductal_Adenocarcinoma-1|TCGA-Pancreas / Sample_Type by Project: Shred V9 | 2.77e-05 | 186 | 208 | 7 | 03db813598b67b1e08f759758a1c2023396921fa | |
| ToppCell | renal_medulla_nuclei-CKD+DKD_normotensive-Epithelial-Distal_tubule_epithelial_cell-kidney_loop_of_Henle_thick_ascending_limb_epithelial_cell-Cortical_Thick_Ascending_Limb_Cell|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 2.86e-05 | 187 | 208 | 7 | b93cf4dfe8ffb89348ee7bccc9f284189f7240a2 | |
| ToppCell | droplet-Lung-18m-Mesenchymal-myofibroblast-tracheobronchial_smooth_muscle_cell-smooth_muscle_cell_of_trachea_l39|18m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 2.86e-05 | 187 | 208 | 7 | 218c9b4f28499389c43005d9626af2ac01066027 | |
| ToppCell | CD8+_Memory_T_cell-CV-4|CD8+_Memory_T_cell / cell class, Virus stimulation and cluster | 2.86e-05 | 187 | 208 | 7 | 9c2fc2f259fa7d3a65fb99c295ac378e03d9aa6c | |
| ToppCell | droplet-Lung-18m-Mesenchymal-myofibroblast-tracheobronchial_smooth_muscle_cell|18m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 2.86e-05 | 187 | 208 | 7 | c7ac4b328efc2ebb72f71154661914193ff402ca | |
| ToppCell | droplet-Bladder-nan|Bladder / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.86e-05 | 187 | 208 | 7 | 663991a8afe652e92363b64bcbd68c14d0307f0e | |
| ToppCell | 390C-Lymphocytic-CD4_T-cell-Treg_cell_3|CD4_T-cell / Donor, Lineage, Cell class and subclass (all cells) | 2.86e-05 | 187 | 208 | 7 | 1eed2c1a05e80a7c8f639437c117afe0c18dfb0c | |
| ToppCell | RA-10._Endothelium_II|World / Chamber and Cluster_Paper | 3.06e-05 | 189 | 208 | 7 | 75c248b9de5e2fb7a0baa8cdbab516e575cc4394 | |
| ToppCell | renal_cortex_nuclei-CKD+DKD_normotensive-Epithelial-Distal_tubule_epithelial_cell-kidney_distal_convoluted_tubule_epithelial_cell|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 3.06e-05 | 189 | 208 | 7 | e32172ad09e93f6ac6ea2b92145b2b73003f7970 | |
| ToppCell | facs-Heart-RA-3m-Mesenchymal-valve_cell|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.17e-05 | 190 | 208 | 7 | bfbdf16d488359d7935a419c4c1823288f39c183 | |
| ToppCell | renal_papilla_nuclei-Adult_normal_reference-Mesenchymal-Myocytic_interstitial_cell-Myofibroblast-|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 3.17e-05 | 190 | 208 | 7 | 562ee3b025c29edf07b8b344323edb49d82f1c7e | |
| ToppCell | facs-Heart-RA-3m-Mesenchymal-valve_cell|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.17e-05 | 190 | 208 | 7 | eb1f8bb4d903b08e50c2dc173b06c0c79d8e316e | |
| ToppCell | renal_papilla_nuclei-Adult_normal_reference-Mesenchymal-Myocytic_interstitial_cell-Myofibroblast|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 3.17e-05 | 190 | 208 | 7 | f5fb989afabb49d64d91324570cd8c80a4b9e67d | |
| ToppCell | droplet-Limb_Muscle-MUSCLE-30m-Mesenchymal-smooth_muscle_cell|Limb_Muscle / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.17e-05 | 190 | 208 | 7 | 1ab3f19f1ce9f58e5125135704d94655a2e330a0 | |
| ToppCell | P15-Mesenchymal-myocytic_cell-vascular_associated_smooth_muscle_cell|P15 / developmental_time, Lineage, Cell group, Cell type, Cell type_cellcyc-phase | 3.39e-05 | 192 | 208 | 7 | a476895b7b252c388d6346eacbc72f0115b1443e | |
| ToppCell | 3'-GW_trimst-1.5-LargeIntestine-Mesenchymal-Pericytes|GW_trimst-1.5 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 3.50e-05 | 193 | 208 | 7 | a9349ed5f3c34dcf817b3e84737e5946922ddff3 | |
| ToppCell | PND14-Mesenchymal-Mesenchymal_myocytic-Myofibroblast_vascular-VSMC-VSMC_mature|PND14 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 3.50e-05 | 193 | 208 | 7 | 9a2c1711dec9dd8c8313bcf25bb888ac8e86c3f3 | |
| ToppCell | TCGA-Prostate-Primary_Tumor-Prostate_Adenocarcinoma-Acinar_Adenocarcinoma-6|TCGA-Prostate / Sample_Type by Project: Shred V9 | 3.50e-05 | 193 | 208 | 7 | abd71b2cf667ef2b1c4d88acd0c1dd19a12ff659 | |
| ToppCell | PND14-Mesenchymal-Mesenchymal_myocytic-Myofibroblast_vascular-VSMC|PND14 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 3.50e-05 | 193 | 208 | 7 | 7c7aa5e2124830d0fa1df11b6413ec6cf780aad0 | |
| ToppCell | P28-Mesenchymal-myocytic_cell|P28 / developmental_time, Lineage, Cell group, Cell type, Cell type_cellcyc-phase | 3.62e-05 | 194 | 208 | 7 | 83e45441c74b7f50b6725876b583229280179dc2 | |
| ToppCell | PND28-Mesenchymal-Mesenchymal_myocytic-Myofibroblast_vascular|PND28 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 3.62e-05 | 194 | 208 | 7 | aaecde88bd54134a938e76cdf059c1c2653e4e77 | |
| ToppCell | Smart-start-Cell-Wel_seq-Non-neoplastic-Vascular-Mural_cell-Scavenging_endothelial|Smart-start-Cell-Wel_seq / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 3.62e-05 | 194 | 208 | 7 | cceb7c88492bb6cd531e1c2651638da1ddf30931 | |
| ToppCell | Smart-start-Cell-Wel_seq-Non-neoplastic-Vascular-Mural_cell-Scavenging_endothelial-G|Smart-start-Cell-Wel_seq / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 3.62e-05 | 194 | 208 | 7 | ea5e1bc8d9e27cabfe1fb833ca47ec0893593b12 | |
| ToppCell | 10x5'v1-week_17-19-Endothelial-stroma-sinusoidal_EC|week_17-19 / cell types per 3 fetal stages;per 3',per 5' | 3.74e-05 | 195 | 208 | 7 | 22a481927147ec4ae9d59e6af7c87df0e9cb51e4 | |
| ToppCell | 5'-GW_trimst-1.5-SmallIntestine-Mesenchymal-Pericytes|GW_trimst-1.5 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 3.74e-05 | 195 | 208 | 7 | 815ac5dacd382b11abb32011ed1c0635b0ddc779 | |
| ToppCell | PND28-Mesenchymal-Mesenchymal_myocytic|PND28 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 3.86e-05 | 196 | 208 | 7 | 4740ef6e428f1ccc81fc98c3b868afd38ce60535 | |
| ToppCell | control-immature_Neutrophil|control / Cohort 1 (10x PBMC) with disease condition, cell group and cell class | 3.86e-05 | 196 | 208 | 7 | e34fd3e7a5b1c22a81fd3208e6d58bdb846d51c4 | |
| ToppCell | PND14-Mesenchymal-Mesenchymal_myocytic-Myofibroblast_vascular|PND14 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 3.99e-05 | 197 | 208 | 7 | 1a6b2ca94a4634c24cd95481576c955b20000a5f | |
| ToppCell | 10x_3'_v2v3-Non-neoplastic-Glial-Neuronal-Astrocyte-Astrocyte|10x_3'_v2v3 / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 3.99e-05 | 197 | 208 | 7 | bd7e18a0fed085cfb8ed0e478d1f172a173febbe | |
| ToppCell | 10x_3'_v2v3-Non-neoplastic-Glial-Neuronal-Astrocyte-Astrocyte-F|10x_3'_v2v3 / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 3.99e-05 | 197 | 208 | 7 | 7e06aee2add54eeff4a9927d9b04b5797160113b | |
| ToppCell | droplet-Mammary_Gland-nan-3m-Epithelial|Mammary_Gland / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.99e-05 | 197 | 208 | 7 | b1c6a15bf6c0645952a7247182dc71baf4736869 | |
| ToppCell | 10x_3'_v2v3-Non-neoplastic-Glial-Neuronal-Astrocyte|10x_3'_v2v3 / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 3.99e-05 | 197 | 208 | 7 | 5bcf963f21d23edafef1e90dc1de24cd3b0fccce | |
| ToppCell | BAL-Severe-Epithelial-Epithelial-AT1/AT2|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 4.12e-05 | 198 | 208 | 7 | aed0476248e9637897eefb1623ec4035f2dacd82 | |
| ToppCell | BAL-Severe-Epithelial-Epithelial-AT1/AT2|Severe / Location, Disease Group, Cell group, Cell class (2021.03.09) | 4.12e-05 | 198 | 208 | 7 | e115eea04012e9e492e923ed080e1723c38d14fd | |
| ToppCell | LPS_only-Epithelial_alveolar-AT_2|LPS_only / Treatment groups by lineage, cell group, cell type | 4.12e-05 | 198 | 208 | 7 | d087e738d69ca9853553fde46d4e7a8906439d32 | |
| ToppCell | BAL-Severe-Epithelial-Epithelial-AT1/AT2-|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 4.12e-05 | 198 | 208 | 7 | 691a2f1779225e5519155460eeb6a2aac5f67a92 | |
| ToppCell | Tracheal-NucSeq-Stromal-Myofibroblastic-Muscle_perivascular_immune_recruiting|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 4.12e-05 | 198 | 208 | 7 | b7e900fc0a1b3fa5e47dcc36ce6b0c3ce6bf9739 | |
| ToppCell | BAL-Severe-Epithelial-Epithelial-AT1/AT2-|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.09) | 4.12e-05 | 198 | 208 | 7 | 33d1e0b6f57663544bee0ffdde83a65da764d44c | |
| ToppCell | Severe_COVID-19-Epithelial-AT1/AT2|Severe_COVID-19 / Disease group,lineage and cell class （2021.01.30） | 4.12e-05 | 198 | 208 | 7 | 43e33d28d9de5033bd00d39be953542a225236ed | |
| ToppCell | COVID-19-COVID-19_Mild-Myeloid-Neutrophil|COVID-19_Mild / Disease, condition lineage and cell class | 4.25e-05 | 199 | 208 | 7 | 9f6b6731186ef399f952a75879eba66fd8ed3494 | |
| ToppCell | LPS_IL1RA_TNF-Epithelial_alveolar-AT_1-Differentiating_AT2|LPS_IL1RA_TNF / Treatment groups by lineage, cell group, cell type | 4.25e-05 | 199 | 208 | 7 | 121de4e02585de3a3010398387c523bacf8ce546 | |
| ToppCell | control-Neutrophil|control / Cohort 1 (10x PBMC) with disease condition, cell group and cell class | 4.39e-05 | 200 | 208 | 7 | b5d197472799cc61d7497faed91ac2564ae4930a | |
| ToppCell | control-HLA-DR-_S100A+_Monocyte|control / Cohort 1 (10x PBMC) with disease condition, cell group and cell class | 4.39e-05 | 200 | 208 | 7 | 9e3e13a68bc1110fa000ec2d80f4c654ddbce17e | |
| Computational | Genes in the cancer module 318. | 2.43e-05 | 28 | 137 | 5 | MODULE_318 | |
| Drug | PD98059 | RPS6KA5 NFKB2 CDON ROCK2 RPS6KA4 RBL2 MAPK14 LRP6 ROCK1 MAPK4 MAPK6 IKBKB MAPK13 | 2.35e-07 | 233 | 207 | 13 | CID000004713 |
| Drug | Resveratrol [501-36-0]; Up 200; 17.6uM; MCF7; HT_HG-U133A | MYO1E TCP11L1 ZC3H13 SLC24A3 PAQR6 TBC1D4 KCNH2 RPS6KA4 PPFIBP2 LRP6 MACF1 MAPK13 | 3.01e-07 | 199 | 207 | 12 | 5509_UP |
| Drug | wartmannin | MYH8 CLTCL1 MYO1E RPS6KA5 MYO10 PDPK1 TBC1D4 NFKB2 ROCK2 MRE11 RPS6KA4 RASA1 RBL2 MYO1B XRCC5 LEFTY1 MAPK14 ROCK1 PRKDC MAPK4 MAPK6 IKBKB MAPK13 ADAP2 | 4.04e-07 | 811 | 207 | 24 | CID000005691 |
| Drug | BAPTA-AM | RYR3 KCNH2 NFKB2 ROCK2 MRE11 CACNA2D1 RBL2 MAPK14 LRP6 ROCK1 MAPK4 MAPK6 IKBKB MAPK13 | 5.28e-07 | 293 | 207 | 14 | CID000002293 |
| Drug | Cromolyn disodium salt [15826-37-6]; Up 200; 7.8uM; MCF7; HT_HG-U133A | MYO1E ZC3H13 SLC24A3 IL17RA CDON RPS6KA4 TNPO2 ADGRL1 HIPK3 PPM1F IKBKB | 1.92e-06 | 196 | 207 | 11 | 3475_UP |
| Drug | Esculetin [305-01-1]; Down 200; 22.4uM; MCF7; HT_HG-U133A | MYO10 AP2A2 NFKB2 EIF3M PPFIBP2 NUP98 MAPK14 FEZ1 LRP6 ARHGAP45 EDRF1 | 2.22e-06 | 199 | 207 | 11 | 6499_DN |
| Drug | Urosiol [128-13-2]; Down 200; 10.2uM; MCF7; HT_HG-U133A | RRP1B PAQR6 CNOT8 AP2A2 NOTCH3 PPFIBP2 NUP98 ADGRL1 VPS13D DZIP3 IKBKB | 2.33e-06 | 200 | 207 | 11 | 6484_DN |
| Drug | celiprolol | 4.13e-06 | 47 | 207 | 6 | CID000002663 | |
| Drug | SB202474 | 6.19e-06 | 14 | 207 | 4 | CID000005162 | |
| Drug | AD 288 | 6.19e-06 | 14 | 207 | 4 | CID000073553 | |
| Drug | Quercetine dihydrate [6151-25-3]; Down 200; 11.8uM; MCF7; HT_HG-U133A | 6.20e-06 | 180 | 207 | 10 | 2859_DN | |
| Drug | apocynin | PSMD2 RYR3 DUOX1 NFKB2 ROCK2 MAPK14 ROCK1 MAPK4 MAPK6 MAPK13 | 8.27e-06 | 186 | 207 | 10 | CID000002214 |
| Drug | NSC226080 | MYH8 CLTCL1 HK2 RPS6KA5 PDPK1 ANKHD1 RYR3 TBC1D4 UTP15 TBC1D1 NFKB2 CUL4B ROCK2 RPS6KA4 KRT18 MAPK14 LRP6 ROCK1 MAPK4 MAPK6 MAPK13 | 9.98e-06 | 782 | 207 | 21 | CID000005040 |
| Drug | Digitoxigenin [143-62-4]; Down 200; 10.6uM; PC3; HT_HG-U133A | IL17RA HSPG2 RBL2 ASTE1 ECPAS TRIM45 VPS13D GEMIN4 WDFY3 ARHGAP45 | 1.04e-05 | 191 | 207 | 10 | 4217_DN |
| Drug | DEAC | 1.05e-05 | 55 | 207 | 6 | CID000007277 | |
| Drug | Ampyrone [83-07-8]; Down 200; 19.6uM; MCF7; HT_HG-U133A | MAN1A1 RPS6KA5 AP2A2 ADGRL1 RGS12 HIPK3 MAPK14 LRP6 MAPK13 ADAP2 | 1.25e-05 | 195 | 207 | 10 | 6845_DN |
| Drug | Pyrimethamine [58-14-0]; Up 200; 16uM; PC3; HG-U133A | UGGT1 CNOT8 AP2A2 TARBP1 RBL2 ADGRL1 TRIM45 VPS13D KLHL25 IKBKB | 1.31e-05 | 196 | 207 | 10 | 1894_UP |
| Drug | Homatropine hydrobromide (R,S) [51-56-9]; Down 200; 11.2uM; MCF7; HT_HG-U133A | MYO1E PDPK1 SLC24A3 USP19 TBC1D4 AP2A2 IL17RA NOTCH3 SLC11A2 PPM1F | 1.31e-05 | 196 | 207 | 10 | 1684_DN |
| Drug | Midecamycin [35457-80-8]; Down 200; 5uM; MCF7; HT_HG-U133A | MAN1A1 MYO10 TCP11L1 CUL9 KCNH2 IPO8 KLHL25 DZIP3 WDFY3 EDRF1 | 1.37e-05 | 197 | 207 | 10 | 1526_DN |
| Drug | N6,2-O-dibutyryladenosine 3,5-cyclic monophosphate sodium salt; Up 200; 2uM; MCF7; HT_HG-U133A_EA | ABCA3 MAN2C1 SLC24A3 PAQR6 NFKB2 SLC4A8 PTPRU VPS13D KLHL25 DZIP3 | 1.37e-05 | 197 | 207 | 10 | 959_UP |
| Drug | vinblastine sulfate; Up 200; 0.1uM; MCF7; HT_HG-U133A | MYO10 ARHGAP29 SLC11A2 RASA1 RBL2 MYO1B ORC2 MAPK14 FEZ1 PUM1 | 1.37e-05 | 197 | 207 | 10 | 7551_UP |
| Drug | haloperidol; Down 200; 10uM; PC3; HT_HG-U133A | RRP1B ACTN1 IL17RA NOTCH3 RAD51D RPS6KA4 ADGRL1 PDLIM4 ZNF35 IKBKB | 1.43e-05 | 198 | 207 | 10 | 1244_DN |
| Drug | Benzydamine hydrochloride [132-69-4]; Up 200; 11.6uM; HL60; HG-U133A | RPS6KA5 RRP1B MYCBP2 AP2A2 EIF3M RASA1 VPS13D ZNF35 GEMIN4 MACF1 | 1.49e-05 | 199 | 207 | 10 | 1552_UP |
| Drug | Clorocruoro Hem | 1.72e-05 | 123 | 207 | 8 | CID003518809 | |
| Drug | LY294002 | MYH8 RPS6KA5 PDPK1 ACTN1 NFKB2 ROCK2 RPS6KA4 RASA1 RBL2 PPFIBP2 LEFTY1 MAPK14 ROCK1 TNKS PRKDC MAPK4 MAPK6 TNKS2 IKBKB MAPK13 | 1.75e-05 | 748 | 207 | 20 | CID000003973 |
| Drug | NSC339663 | MYH8 CLTCL1 MYO1E MYO10 ACTN1 TBC1D4 ROCK2 MYO1B ROCK1 MAPK4 MAPK6 | 1.94e-05 | 250 | 207 | 11 | CID000003892 |
| Drug | SB202190 | 3.19e-05 | 134 | 207 | 8 | CID005353940 | |
| Drug | tempol | 3.67e-05 | 221 | 207 | 10 | CID000137994 | |
| Drug | NSC-364372 | CLTCL1 NFKB2 DDX24 MRE11 IPO8 RBL2 TNPO2 NMD3 MAPK14 FANCI GEMIN4 MAPK4 MAPK6 IKBKB MAPK13 | 3.96e-05 | 484 | 207 | 15 | CID000435143 |
| Drug | Primaquine diphosphate [63-45-6]; Down 200; 8.8uM; MCF7; HT_HG-U133A | 5.84e-05 | 188 | 207 | 9 | 4845_DN | |
| Drug | Nilutamide [63612-50-0]; Down 200; 12.6uM; MCF7; HT_HG-U133A | 6.34e-05 | 190 | 207 | 9 | 5362_DN | |
| Drug | oleoyl-lysophosphatidic acid | ENPP6 CLTCL1 RPS6KA5 NFKB2 ROCK2 RPS6KA4 RBL2 LEFTY1 MAPK14 ROCK1 MAPK4 MAPK6 MAPK13 | 6.46e-05 | 391 | 207 | 13 | CID000003987 |
| Drug | 17-AAG; Down 200; 1uM; ssMCF7; HG-U133A | 6.60e-05 | 191 | 207 | 9 | 521_DN | |
| Drug | 5230742; Down 200; 17uM; MCF7; HT_HG-U133A_EA | 6.87e-05 | 192 | 207 | 9 | 970_DN | |
| Drug | MEK1/2 inhibitor | RPS6KA5 TBC1D4 NFKB2 RPS6KA4 LEFTY1 MAPK14 MAPK4 MAPK6 MAPK13 | 7.15e-05 | 193 | 207 | 9 | CID009549284 |
| Drug | Chlorpromazine hydrochloride [69-09-0]; Down 200; 11.2uM; PC3; HT_HG-U133A | 7.15e-05 | 193 | 207 | 9 | 5074_DN | |
| Drug | Ceforanide [60925-61-3]; Down 200; 7.6uM; PC3; HT_HG-U133A | 7.15e-05 | 193 | 207 | 9 | 6751_DN | |
| Drug | DENSPM | 7.38e-05 | 48 | 207 | 5 | CID000004282 | |
| Drug | Ethoxyquin [91-53-2]; Up 200; 18.4uM; MCF7; HT_HG-U133A | 7.44e-05 | 194 | 207 | 9 | 3846_UP | |
| Drug | semustine; Down 200; 100uM; MCF7; HT_HG-U133A | 7.74e-05 | 195 | 207 | 9 | 7540_DN | |
| Drug | Alfadolone acetate [23930-37-2]; Down 200; 10.2uM; MCF7; HT_HG-U133A | 8.05e-05 | 196 | 207 | 9 | 6506_DN | |
| Drug | Aceclofenac [89796-99-6]; Up 200; 11.2uM; PC3; HT_HG-U133A | 8.05e-05 | 196 | 207 | 9 | 7269_UP | |
| Drug | carmustine; Up 200; 100uM; MCF7; HT_HG-U133A | 8.05e-05 | 196 | 207 | 9 | 6888_UP | |
| Drug | Demecarium bromide [56-94-0]; Down 200; 5.6uM; PC3; HT_HG-U133A | 8.05e-05 | 196 | 207 | 9 | 5795_DN | |
| Drug | Rockout | 8.23e-05 | 2 | 207 | 2 | CID000644354 | |
| Drug | 3,3-dimethylacryloyl chloride | 8.23e-05 | 2 | 207 | 2 | CID000102394 | |
| Drug | Norgestrel-(-)-D [797-63-7]; Down 200; 12.8uM; HL60; HT_HG-U133A | 8.37e-05 | 197 | 207 | 9 | 2547_DN | |
| Drug | Aconitine [302-27-2]; Down 200; 6.2uM; MCF7; HT_HG-U133A | 8.37e-05 | 197 | 207 | 9 | 6797_DN | |
| Drug | Pyrilamine maleate [59-33-6]; Down 200; 10uM; MCF7; HT_HG-U133A | 8.37e-05 | 197 | 207 | 9 | 7223_DN | |
| Drug | Dehydrocholic acid [81-23-2]; Up 200; 9.6uM; PC3; HT_HG-U133A | 8.37e-05 | 197 | 207 | 9 | 4620_UP | |
| Drug | Miconazole [22916-47-8]; Up 200; 9.6uM; HL60; HG-U133A | 8.37e-05 | 197 | 207 | 9 | 1977_UP | |
| Drug | Doxazosin mesylate [77883-43-3]; Down 200; 7.4uM; MCF7; HT_HG-U133A | 8.37e-05 | 197 | 207 | 9 | 3363_DN | |
| Drug | Medrysone [2668-66-8]; Down 200; 11.6uM; HL60; HT_HG-U133A | 8.37e-05 | 197 | 207 | 9 | 2544_DN | |
| Drug | valdecoxib; Down 200; 10uM; PC3; HT_HG-U133A | 8.37e-05 | 197 | 207 | 9 | 6408_DN | |
| Drug | iloprost; Up 200; 1uM; MCF7; HG-U133A | TCP11L1 FAM114A2 ACTN1 TARBP1 BRWD1 ASTE1 VPS13D KLHL25 IKBKB | 8.70e-05 | 198 | 207 | 9 | 488_UP |
| Drug | Niridazole [61-57-4]; Down 200; 18.6uM; PC3; HT_HG-U133A | ABCA3 MAN1A1 FAM114A2 NOTCH3 SLC4A8 RBL2 ADGRL1 VPS13D WDFY3 | 8.70e-05 | 198 | 207 | 9 | 4621_DN |
| Drug | 2-propylpentanoic acid; Up 200; 50uM; MCF7; HT_HG-U133A_EA | 8.70e-05 | 198 | 207 | 9 | 1002_UP | |
| Drug | 11-deoxy-16,16-dimethyl Prostaglandin E2; Down 200; 10uM; MCF7; HT_HG-U133A | 8.70e-05 | 198 | 207 | 9 | 7514_DN | |
| Drug | AC1NDP1U | 8.87e-05 | 115 | 207 | 7 | CID004629339 | |
| Drug | Riboflavine [83-88-5]; Down 200; 10.6uM; MCF7; HT_HG-U133A | 9.04e-05 | 199 | 207 | 9 | 6822_DN | |
| Drug | Captopril [62571-86-2]; Down 200; 17.2uM; MCF7; HT_HG-U133A | 9.04e-05 | 199 | 207 | 9 | 1488_DN | |
| Drug | Vitamin K2 [11032-49-8]; Down 200; 9uM; PC3; HT_HG-U133A | 9.04e-05 | 199 | 207 | 9 | 4534_DN | |
| Drug | Proparacaine hydrochloride [5875-06-9]; Down 200; 12uM; MCF7; HT_HG-U133A | 9.04e-05 | 199 | 207 | 9 | 6492_DN | |
| Drug | C070379 | 9.04e-05 | 199 | 207 | 9 | CID003034747 | |
| Drug | Phenindione [83-12-5]; Down 200; 18uM; HL60; HG-U133A | 9.04e-05 | 199 | 207 | 9 | 1718_DN | |
| Drug | blebbistatin | 9.36e-05 | 116 | 207 | 7 | CID003476986 | |
| Drug | Dipyrone [5907-38-0]; Down 200; 12uM; HL60; HT_HG-U133A | 9.40e-05 | 200 | 207 | 9 | 2175_DN | |
| Drug | Acetaminophen [103-90-2]; Down 200; 26.4uM; PC3; HT_HG-U133A | 9.40e-05 | 200 | 207 | 9 | 6284_DN | |
| Drug | Rilmenidine hemifumarate [54187-04-1]; Down 200; 8.4uM; MCF7; HT_HG-U133A | 9.40e-05 | 200 | 207 | 9 | 6512_DN | |
| Drug | Vancomycin hydrochloride [1404-93-9]; Down 200; 2.6uM; PC3; HT_HG-U133A | 9.40e-05 | 200 | 207 | 9 | 4598_DN | |
| Drug | Atractyloside potassium salt [102130-43-8]; Up 200; 5uM; HL60; HT_HG-U133A | 9.40e-05 | 200 | 207 | 9 | 2573_UP | |
| Drug | Isotretinoin [4759-48-2]; Down 200; 13.4uM; PC3; HT_HG-U133A | 9.40e-05 | 200 | 207 | 9 | 7315_DN | |
| Drug | NSC611747 | MYH8 MYO1E RPS6KA5 MYO10 PDPK1 ACTN1 ROCK2 RPS6KA4 MYO1B MAPK14 ROCK1 MAPK13 | 9.77e-05 | 352 | 207 | 12 | CID000002534 |
| Drug | B0683 | 9.88e-05 | 117 | 207 | 7 | CID006398969 | |
| Drug | lysosphingomyelin | 1.12e-04 | 160 | 207 | 8 | CID000005263 | |
| Drug | AC1L73CW | 1.18e-04 | 84 | 207 | 6 | CID000328776 | |
| Drug | AICAR monophosphate | 1.27e-04 | 163 | 207 | 8 | CID000000200 | |
| Drug | NSC618487 | MYO1E RPS6KA5 PDPK1 PSMD2 DUOX1 NFKB2 ROCK2 CACNA2D1 LEFTY1 MAPK14 FEZ1 PRKAA1 DGKI ROCK1 TNKS PRKDC MAPK4 MAPK6 TNKS2 IKBKB MAPK13 | 1.28e-04 | 933 | 207 | 21 | CID000005279 |
| Drug | Pkcs | 1.41e-04 | 211 | 207 | 9 | CID000164073 | |
| Drug | eye gene | MYH8 MYO1E RPS6KA5 MYO10 ROCK2 CACNA2D1 MYO1B MAPK14 ROCK1 MAPK4 MAPK6 MAPK13 | 1.52e-04 | 369 | 207 | 12 | CID000004782 |
| Drug | oxanol | 1.53e-04 | 12 | 207 | 3 | CID000136505 | |
| Drug | p38 MAP kinase inhibitor | 1.91e-04 | 130 | 207 | 7 | CID000004665 | |
| Drug | STO-609 | 1.95e-04 | 32 | 207 | 4 | CID003467590 | |
| Drug | 2-MeSAMP | 1.98e-04 | 13 | 207 | 3 | CID000189762 | |
| Drug | ebselen | 2.00e-04 | 131 | 207 | 7 | CID000003194 | |
| Drug | A61603 | 2.21e-04 | 33 | 207 | 4 | CID004038180 | |
| Drug | BRL-32872 | 2.45e-04 | 3 | 207 | 2 | CID000656770 | |
| Drug | sildenafil | 2.47e-04 | 96 | 207 | 6 | CID000005212 | |
| Drug | AC1NSKHR | 2.49e-04 | 34 | 207 | 4 | CID005311362 | |
| Drug | AC1L1JG6 | 2.50e-04 | 14 | 207 | 3 | CID000005026 | |
| Drug | Ellipticine [519-23-3]; Down 200; 16.2uM; PC3; HT_HG-U133A | 2.51e-04 | 180 | 207 | 8 | 5779_DN | |
| Drug | 5'-GMP Na2 | PDE1A HINT1 PDE10A NFKB2 ROCK2 NUBP2 MAPK14 MAPK4 MAPK6 IKBKB MAPK13 | 2.63e-04 | 335 | 207 | 11 | CID000000761 |
| Drug | BAY 11-7082 | 2.76e-04 | 98 | 207 | 6 | CID000002301 | |
| Drug | geranylgeranyl pyrophosphate | 2.87e-04 | 139 | 207 | 7 | CID000000735 | |
| Drug | Adamantamine fumarate [80789-67-9]; Down 200; 9.6uM; HL60; HT_HG-U133A | 2.91e-04 | 184 | 207 | 8 | 1344_DN | |
| Drug | ICI 182,780; Down 200; 1uM; MCF7; HT_HG-U133A | 3.01e-04 | 185 | 207 | 8 | 6965_DN | |
| Drug | GF109203X | RPS6KA5 PDPK1 KCNH2 ROCK2 RPS6KA4 RBL2 MAPK14 ROCK1 MAPK4 MAPK6 MAPK13 | 3.06e-04 | 341 | 207 | 11 | CID000002396 |
| Drug | Felodipine [72509-76-3]; Up 200; 10.4uM; MCF7; HT_HG-U133A | 3.24e-04 | 187 | 207 | 8 | 5294_UP | |
| Drug | Benzbromarone [3562-84-3]; Up 200; 9.4uM; HL60; HT_HG-U133A | 3.48e-04 | 189 | 207 | 8 | 1291_UP | |
| Drug | AC1L1H7K | 3.56e-04 | 144 | 207 | 7 | CID000004010 | |
| Disease | Malignant neoplasm of breast | NAT2 ABCA3 MAN2C1 ATP7B PDPK1 EFCAB13 DDX10 ARHGAP29 UTP20 EIF3M NOTCH3 MRE11 KRT18 NUP98 ZDHHC4 THOC5 CUL5 SLC39A12 NSUN6 TCL1B PPM1F PRKAA1 MACF1 ADAM33 IKBKB | 1.02e-07 | 1074 | 202 | 25 | C0006142 |
| Disease | rectum cancer (is_implicated_in) | 2.58e-05 | 9 | 202 | 3 | DOID:1993 (is_implicated_in) | |
| Disease | age at menopause | TUBGCP4 CNOT8 PLCL1 EIF3M XRCC5 TFAP2C KLHL25 FANCI DNAJC11 PRKDC | 4.80e-05 | 302 | 202 | 10 | EFO_0004704 |
| Disease | Shortened QT interval | 5.01e-05 | 11 | 202 | 3 | C0151879 | |
| Disease | lysophosphatidylcholine 20:4 measurement | 6.60e-05 | 32 | 202 | 4 | EFO_0010363 | |
| Disease | N,N,N-trimethyl-5-aminovalerate measurement | 1.35e-04 | 15 | 202 | 3 | EFO_0800090 | |
| Disease | Microcephaly and chorioretinopathy | 1.39e-04 | 3 | 202 | 2 | cv:CN263236 | |
| Disease | Autosomal recessive chorioretinopathy-microcephaly syndrome | 1.39e-04 | 3 | 202 | 2 | cv:C3502492 | |
| Disease | Microcephaly with Chorioretinopathy, Autosomal Recessive | 1.39e-04 | 3 | 202 | 2 | C3502492 | |
| Disease | diastolic blood pressure, alcohol drinking | 1.67e-04 | 118 | 202 | 6 | EFO_0004329, EFO_0006336 | |
| Disease | Short QT Syndrome 1 | 2.77e-04 | 4 | 202 | 2 | C1865020 | |
| Disease | Chediak-Higashi syndrome (implicated_via_orthology) | 2.77e-04 | 4 | 202 | 2 | DOID:2935 (implicated_via_orthology) | |
| Disease | X-24020 measurement | 4.60e-04 | 5 | 202 | 2 | EFO_0022128 | |
| Disease | airway responsiveness measurement | 5.75e-04 | 24 | 202 | 3 | EFO_0006897 | |
| Disease | Brugada Syndrome (disorder) | 5.75e-04 | 24 | 202 | 3 | C1142166 | |
| Disease | mosquito bite reaction size measurement | 6.74e-04 | 212 | 202 | 7 | EFO_0008378 | |
| Disease | colipase measurement | 6.87e-04 | 6 | 202 | 2 | EFO_0801485 | |
| Disease | methionine measurement | 7.32e-04 | 26 | 202 | 3 | EFO_0009771 | |
| Disease | very low density lipoprotein cholesterol measurement, lipid measurement | 8.37e-04 | 220 | 202 | 7 | EFO_0004529, EFO_0008317 | |
| Disease | very low density lipoprotein cholesterol measurement, phospholipid measurement | 1.06e-03 | 229 | 202 | 7 | EFO_0004639, EFO_0008317 | |
| Disease | response to sulfonylurea, QT interval | 1.35e-03 | 32 | 202 | 3 | EFO_0004682, EFO_0007922 | |
| Disease | dihydroxy docosatrienoic acid measurement | 1.35e-03 | 32 | 202 | 3 | EFO_0005275 | |
| Disease | cholesteryl esters:total lipids ratio, high density lipoprotein cholesterol measurement | 1.49e-03 | 243 | 202 | 7 | EFO_0004612, EFO_0020944 | |
| Disease | renin measurement, hypertension | 1.63e-03 | 9 | 202 | 2 | EFO_0000537, EFO_0010616 | |
| Disease | colon cancer (is_implicated_in) | 1.91e-03 | 36 | 202 | 3 | DOID:219 (is_implicated_in) | |
| Disease | age of onset of depressive disorder, wellbeing measurement | 2.02e-03 | 10 | 202 | 2 | EFO_0007869, OBA_2040166 | |
| Disease | Uterine leiomyoma, estrogen-receptor negative breast cancer | 2.02e-03 | 10 | 202 | 2 | EFO_1000650, HP_0000131 | |
| Disease | carboxypeptidase B2 measurement | 2.02e-03 | 10 | 202 | 2 | EFO_0008069 | |
| Disease | pneumonia (implicated_via_orthology) | 2.02e-03 | 10 | 202 | 2 | DOID:552 (implicated_via_orthology) | |
| Disease | very low density lipoprotein cholesterol measurement | 2.18e-03 | 260 | 202 | 7 | EFO_0008317 | |
| Disease | glycine measurement | 2.58e-03 | 137 | 202 | 5 | EFO_0009767 | |
| Disease | N-acetylputrescine measurement | 2.94e-03 | 12 | 202 | 2 | EFO_0800127 | |
| Disease | rectum cancer | 2.98e-03 | 42 | 202 | 3 | EFO_1000657 | |
| Disease | Malignant neoplasm of liver | 3.01e-03 | 142 | 202 | 5 | C0345904 | |
| Disease | Liver neoplasms | 3.01e-03 | 142 | 202 | 5 | C0023903 | |
| Disease | cholesterol:total lipids ratio, high density lipoprotein cholesterol measurement | 3.04e-03 | 276 | 202 | 7 | EFO_0004612, EFO_0020943 | |
| Disease | neutrophil count | HINT1 MYO1E MYCBP2 PSMD2 DARS1 IL17RA PLCL1 PRRX1 COPA HECTD4 PCDHA12 MYO1B NLRP3 SLC45A4 SLC39A12 PRKDC MAPK4 TNKS2 ARHGAP45 | 3.15e-03 | 1382 | 202 | 19 | EFO_0004833 |
| Disease | fatty acid measurement | 3.27e-03 | 436 | 202 | 9 | EFO_0005110 | |
| Disease | neurodegenerative disease (implicated_via_orthology) | 3.29e-03 | 145 | 202 | 5 | DOID:1289 (implicated_via_orthology) | |
| Disease | hepatocyte growth factor measurement | 3.41e-03 | 44 | 202 | 3 | EFO_0006903 | |
| Disease | smoking status measurement, ulcerative colitis | 3.46e-03 | 13 | 202 | 2 | EFO_0000729, EFO_0006527 | |
| Disease | Mammary Carcinoma, Human | NAT2 MAN2C1 ATP7B PDPK1 NOTCH3 KRT18 CUL5 NSUN6 TCL1B ADAM33 | 3.49e-03 | 525 | 202 | 10 | C4704874 |
| Disease | Mammary Neoplasms, Human | NAT2 MAN2C1 ATP7B PDPK1 NOTCH3 KRT18 CUL5 NSUN6 TCL1B ADAM33 | 3.49e-03 | 525 | 202 | 10 | C1257931 |
| Disease | neutrophil count, eosinophil count | 3.58e-03 | 213 | 202 | 6 | EFO_0004833, EFO_0004842 | |
| Disease | Mammary Neoplasms | NAT2 MAN2C1 ATP7B PDPK1 NOTCH3 KRT18 CUL5 NSUN6 TCL1B ADAM33 | 3.59e-03 | 527 | 202 | 10 | C1458155 |
| Disease | systemic lupus erythematosus | MAN1A1 DARS1 PLCL1 TARBP1 ANKS1A PRRX1 RPS6KA4 HECTD4 CWC22 WDFY4 OR4A15 TNKS IKBKB | 3.59e-03 | 799 | 202 | 13 | MONDO_0007915 |
| Disease | fibrinogen measurement, tissue plasminogen activator measurement | 3.63e-03 | 45 | 202 | 3 | EFO_0004623, EFO_0004791 | |
| Disease | fibrinogen measurement, plasminogen activator inhibitor 1 measurement | 3.63e-03 | 45 | 202 | 3 | EFO_0004623, EFO_0004792 | |
| Disease | triglycerides:total lipids ratio, low density lipoprotein cholesterol measurement | 3.80e-03 | 150 | 202 | 5 | EFO_0004611, EFO_0020947 | |
| Disease | inositol measurement | 4.02e-03 | 14 | 202 | 2 | EFO_0010504 | |
| Disease | asymmetric dimethylarginine measurement | 4.02e-03 | 14 | 202 | 2 | EFO_0010463 | |
| Disease | congenital hypothyroidism (implicated_via_orthology) | 4.02e-03 | 14 | 202 | 2 | DOID:0050328 (implicated_via_orthology) | |
| Disease | Hereditary Breast and Ovarian Cancer Syndrome | 4.02e-03 | 14 | 202 | 2 | C0677776 | |
| Disease | mean corpuscular hemoglobin concentration | NAT2 ATP7B CCT3 PSMD2 PAQR6 FOCAD TBC1D4 SLC11A2 HECTD4 MYO1B KBTBD2 ZDHHC4 PRKAA1 MACF1 PRKDC ADAP2 | 4.04e-03 | 1105 | 202 | 16 | EFO_0004528 |
| Disease | Breast Carcinoma | NAT2 MAN2C1 ATP7B PDPK1 NOTCH3 KRT18 CUL5 NSUN6 TCL1B ADAM33 | 4.14e-03 | 538 | 202 | 10 | C0678222 |
| Disease | chylomicron measurement, very low density lipoprotein cholesterol measurement, lipid measurement | 4.18e-03 | 95 | 202 | 4 | EFO_0004529, EFO_0008317, EFO_0008596 | |
| Disease | fibrinogen measurement, coronary artery disease | 4.25e-03 | 154 | 202 | 5 | EFO_0001645, EFO_0004623 | |
| Disease | chylomicron measurement, triglyceride measurement, very low density lipoprotein cholesterol measurement | 4.34e-03 | 96 | 202 | 4 | EFO_0004530, EFO_0008317, EFO_0008596 | |
| Disease | triglyceride measurement, very low density lipoprotein cholesterol measurement | 4.57e-03 | 224 | 202 | 6 | EFO_0004530, EFO_0008317 | |
| Disease | neutrophil count, basophil count | 4.57e-03 | 224 | 202 | 6 | EFO_0004833, EFO_0005090 | |
| Disease | glycerate measurement | 4.62e-03 | 15 | 202 | 2 | EFO_0021029 | |
| Disease | anemia (implicated_via_orthology) | 4.62e-03 | 15 | 202 | 2 | DOID:2355 (implicated_via_orthology) | |
| Disease | Atrial Fibrillation | 4.99e-03 | 160 | 202 | 5 | C0004238 | |
| Disease | Cannabis use | 5.25e-03 | 16 | 202 | 2 | EFO_0007585 | |
| Disease | myeloid white cell count | MYO1E PSMD2 DARS1 RMI1 IL17RA HECTD4 MYO1B NLRP3 SLC45A4 SLC39A12 ADAM33 ADGRD2 MAPK4 TNKS2 | 5.37e-03 | 937 | 202 | 14 | EFO_0007988 |
| Disease | Weight Gain | 5.37e-03 | 102 | 202 | 4 | C0043094 | |
| Disease | lifestyle measurement | 5.75e-03 | 235 | 202 | 6 | EFO_0010724 | |
| Disease | serum metabolite measurement | ENPP6 NAT2 MYO1E BCAT1 SLC24A3 PSMD2 DARS1 PDE10A PLCL1 CACNA2D1 PYROXD2 KBTBD2 SLC45A4 SLC39A12 | 5.78e-03 | 945 | 202 | 14 | EFO_0005653 |
| Disease | triglyceride measurement, low density lipoprotein cholesterol measurement | 5.82e-03 | 166 | 202 | 5 | EFO_0004530, EFO_0004611 | |
| Disease | chylomicron measurement, very low density lipoprotein cholesterol measurement | 6.15e-03 | 106 | 202 | 4 | EFO_0008317, EFO_0008596 | |
| Disease | Antithrombotic agent use measurement | 6.38e-03 | 55 | 202 | 3 | EFO_0009925 | |
| Disease | Ischemic stroke, fibrinogen measurement | 6.38e-03 | 55 | 202 | 3 | EFO_0004623, HP_0002140 | |
| Disease | factor XI measurement, fibrinogen measurement, tissue plasminogen activator measurement, factor VII measurement | 6.71e-03 | 56 | 202 | 3 | EFO_0004619, EFO_0004623, EFO_0004694, EFO_0004791 | |
| Disease | chylomicron measurement, very low density lipoprotein cholesterol measurement, phospholipid measurement | 6.78e-03 | 109 | 202 | 4 | EFO_0004639, EFO_0008317, EFO_0008596 |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| DVLHEVMLLDGLASS | 491 | Q9UKU6 | |
| EIGFQLAAAMLHLFD | 1001 | Q8NHU2 | |
| EGAMEDLQDTFIVHT | 526 | P12814 | |
| LDAAGLAENLGLHDM | 156 | Q92754 | |
| IIAMTDGELVAHAFQ | 176 | A6NF34 | |
| EDHQITEVGTMNLFL | 251 | P54687 | |
| EHIISAGLADMVAAA | 316 | Q93034 | |
| TNRDMHGLFDVEISL | 181 | Q6UX41 | |
| EAALAVHTLQSMGVD | 1201 | P35670 | |
| HTATMLLDVLEEGAF | 646 | O94910 | |
| EAIMVLSDFQHDLLA | 401 | Q9BYG8 | |
| ESFHIMLLKDTLQGD | 356 | Q8WXG9 | |
| DIDFGHMEAVNLLSS | 71 | O95782 | |
| IVLTTHFMDEADLLG | 716 | Q99758 | |
| AENHDTFLLAMLLSV | 696 | Q9BZ11 | |
| ALDIHLSDHLMQEGI | 841 | O60706 | |
| HFLGSNVMEEQDLRD | 726 | Q92625 | |
| HAQSLTNMILDDEGV | 506 | Q5JTW2 | |
| SLDVFLGHTNVEELM | 516 | P00736 | |
| FGLLMVENLEEHSEA | 661 | Q2TB18 | |
| DSIVEFMIHNGNLRV | 71 | Q9NPF8 | |
| DIDFGHMEAVNLLSS | 71 | O94973 | |
| ERLHLSEDVAGATFM | 131 | Q8NFF2 | |
| ALMRTLEEGHDFIQE | 231 | Q9Y5Y2 | |
| HAFDIFQMLDVLQEL | 171 | O75771 | |
| VEDFVSLAMVGGHLE | 3976 | P98160 | |
| FLKGDMFIVHNELED | 301 | P20936 | |
| HITFAMLDAVNGNIE | 651 | Q99666 | |
| EIMATEGLHENETLA | 41 | O14775 | |
| AFTDNRDDMALGHVI | 576 | Q9NVR2 | |
| DMDLSGILEQDAFHR | 516 | Q08999 | |
| LGMASQIAEREDHVL | 386 | Q9NRD9 | |
| ASEIIGLLMLEAHHF | 86 | Q9NVI1 | |
| DHVTQGLVELGFILM | 376 | Q9NVI1 | |
| FRGVLHQVMVLDSEA | 531 | Q9NVH1 | |
| EHLEGLMLSLFEQSL | 746 | Q96F46 | |
| LENHQIADSMEFGFL | 1166 | P52948 | |
| ELAMRQSVENDIHGL | 171 | P05783 | |
| DMFQEAHGLVHIDLS | 131 | Q6ZSA7 | |
| SLALEQDLEFGHSMV | 341 | Q92619 | |
| ALEASTHLLVFGMEQ | 91 | O75610 | |
| LNEGHTLDMDLVFLF | 376 | O14920 | |
| FEVTREAMLHLGIDT | 276 | Q96H55 | |
| GALDIMVRTEHAFQL | 1106 | Q3B7T1 | |
| LEQGTLAEEHAKLFM | 116 | P31152 | |
| ILDFGLARHTDDEMT | 166 | Q16539 | |
| AHDVAQVFLDETMIG | 471 | Q8NCI6 | |
| DFIDSLGLLHEQNMA | 261 | Q7L2H7 | |
| ALDEVTAMDNHVAGL | 211 | Q12809 | |
| GLDLVEEDDQFTHML | 356 | Q9HCG8 | |
| EDIMRGSGTQLFDHI | 116 | P52789 | |
| NAFFQGLMLLEEEHA | 1741 | Q5VYK3 | |
| EMNFLLSLDLHFTDG | 106 | Q9P2D6 | |
| LEEATLQHEAMVAAL | 1181 | P13535 | |
| LFAGAHELEQMQLIL | 231 | Q16659 | |
| MDHLFAGAEVILLVV | 131 | Q8NGL6 | |
| FDNIVAIDSLLEHIM | 261 | Q9Y233 | |
| ELEILAMVFAAAIHD | 246 | P54750 | |
| LAVEGMVEELIASHA | 1916 | Q9UM47 | |
| QDAFMQLSHDLLIDI | 166 | Q8IY47 | |
| LFHASALLGDTMVVL | 1786 | Q7Z7M0 | |
| ENGIDIIMADRTFHL | 1276 | Q9HD67 | |
| HKLEEALLFSGQFMD | 2781 | O94854 | |
| ILDFGLARHADAEMT | 166 | O15264 | |
| MNGSALEHVVEFGLD | 691 | O75581 | |
| LLGQVVDHIDSLMEE | 1776 | Q5S007 | |
| DVEHLTGMNDFLNVL | 431 | P49281 | |
| MLHGLLLDQHEEFFI | 191 | Q9UGJ1 | |
| GELFQAFIDTAQHML | 366 | Q9UGJ1 | |
| RHFLLMEDGEFAQSL | 1521 | Q96RT7 | |
| HMSGSELTELLDQVE | 226 | Q99689 | |
| ILFDHNNAVMTDGLE | 366 | O75676 | |
| QLHTFLVMELLNGGE | 491 | O75582 | |
| NGMNTISEEDFAHIL | 381 | Q86XE3 | |
| EGVLLLASAMVAHAD | 341 | A6NGR9 | |
| HVEGLSEEAIMELNL | 196 | Q8N0Y7 | |
| AEDDDESLLGHLMIV | 66 | P49773 | |
| LGTHFQLEAVLADMG | 266 | Q6TCH4 | |
| HSVFMDIFELVVENG | 41 | Q9Y4D8 | |
| HIAALMHDQGEVIAL | 251 | Q8TEA1 | |
| MLLSSEDGDAHVLLQ | 296 | Q8IZL8 | |
| GFFTHILLDEAAQAM | 786 | P42694 | |
| HVNTVMDLEGSDLLA | 476 | Q9H422 | |
| SLDELHILDMIEQGS | 721 | Q86Y13 | |
| ERLHLSEDVAGATFM | 141 | Q9HC58 | |
| SHALEAALEQMDGII | 6 | Q8ND30 | |
| TLEHFQMDALGELSD | 406 | Q9P2V4 | |
| VEFATGEILQMSHIA | 4961 | Q96RW7 | |
| VVTDNLLLGTMAFDH | 121 | Q8NGQ3 | |
| LQEDERLGLSFMDTH | 816 | Q92729 | |
| LREIAGHIMEFSQDQ | 846 | Q14671 | |
| LLDVFREAHAQSIGM | 751 | P25205 | |
| GSHEANMLSVLEIFA | 111 | P12034 | |
| ALENGMHLVDISEFS | 721 | Q52LW3 | |
| RMGHGDEIVLADLNF | 21 | A2VDF0 | |
| EMQLLVVHLSGSFEV | 116 | Q5T6J7 | |
| NAESLLEAGDMLQFH | 116 | Q9H0H3 | |
| LEAGDMLQFHDVRDA | 121 | Q9H0H3 | |
| EIFGEDAMGHTIVLF | 131 | Q9UG22 | |
| ADLEMAAGLTDIFQH | 201 | Q96BQ5 | |
| VILDDGGFLLMANHD | 851 | P54289 | |
| EDHAILQAVIAGDLM | 926 | O75912 | |
| FETAMRLLHDQVGVI | 936 | P53621 | |
| IGFMHSTGRLEIEND | 386 | Q4KMG0 | |
| HVVLDEVDQMLDLGF | 286 | Q9BQ39 | |
| LHNLMGHADEVFVLE | 461 | Q9NSI6 | |
| LVESLVGFEMDITHL | 266 | Q9UBS4 | |
| HMVDIGDIIFTLNEL | 271 | Q8IY85 | |
| FDEFQGLSHLEALEM | 241 | Q9NRY5 | |
| GLSHLEALEMLSQES | 246 | Q9NRY5 | |
| MDLSEHGFGLALLND | 856 | Q9NTJ4 | |
| ILAEFGTLHLEFMHL | 346 | P33908 | |
| QAMELGLEAIFDHIV | 46 | P11245 | |
| MVEKGHFAELSQLLE | 476 | Q9GZR7 | |
| HFAELSQLLEMLNDS | 481 | Q9GZR7 | |
| IMVLSGLELATTFEH | 1581 | Q8IWT3 | |
| IDTLHFAELLMTSGV | 131 | Q9UFF9 | |
| FHATDLQMLVLDEAD | 211 | Q13206 | |
| DRLNVIIFSDHGMTD | 231 | Q6UWR7 | |
| IHLNEMAGDILVFLT | 266 | Q8IX18 | |
| AIMILVGDSLHNFAD | 541 | Q504Y0 | |
| TMFLLNHIVDGSLDE | 261 | Q8IZU8 | |
| DMGLELFRAHIISDQ | 326 | Q13620 | |
| HLEGLSEEAIMELNL | 196 | P18669 | |
| FVSAEEFGHLLDENM | 976 | Q03701 | |
| HISDEQILGFVENLM | 1476 | Q5VW36 | |
| GSHDNITVMVVFLRD | 401 | P49593 | |
| LAMNFHEVLADLGSK | 501 | P0CW18 | |
| AGHSMVLVEVLDVND | 331 | Q9UN75 | |
| GFAEDSDMQLLLHGL | 16 | O60412 | |
| SIAVDMTQHLAEIFG | 576 | O15397 | |
| MGQLFIEHLFGDTDV | 96 | P0C604 | |
| HVDLATLMIDFNGEE | 51 | Q96P20 | |
| MLEVHFVGDDDVLNH | 11 | Q13416 | |
| MDLEGAEDNHLSLLE | 306 | Q96JB3 | |
| AMLQNELEGLGDIFH | 1136 | Q96Q06 | |
| VGEAFQLMGVSLHEL | 66 | Q5VWG9 | |
| MALAHEIVVNGDFQI | 76 | Q9NUJ3 | |
| ALAHEDETIVVGMTN | 296 | Q8TED0 | |
| DIMIEIFNHELFGAV | 1926 | O75691 | |
| LADMRTGVEFTEHLL | 321 | Q9H8W5 | |
| VMSNLVEHNGVLESE | 601 | Q14684 | |
| ILADEHGIIADDMIS | 1461 | O60522 | |
| MNATFLNHSGLEEVD | 1 | Q8N4K4 | |
| GLEMEHRFIDQVLST | 366 | Q7Z6K3 | |
| LGERHTMDLTVEGFQ | 251 | Q9BXJ8 | |
| IISEDQTAALMAHLF | 911 | Q14596 | |
| NLSIHVMDGELDDFS | 301 | Q9H9A7 | |
| FMLGRHGVFLELSED | 296 | Q13200 | |
| FNSGDLLMVDHENFI | 461 | O14975 | |
| ILLNEDMHIQITDFG | 211 | O15530 | |
| AINGESTELMTHLEA | 51 | P50479 | |
| ESMLHELDGLIEQTT | 2881 | Q96Q15 | |
| LQGAEIVFLATDMHL | 136 | Q8IW03 | |
| IHELDEMIGETNALT | 161 | Q9BXF9 | |
| MGIDLVHDEVEAQLL | 206 | Q9BXF9 | |
| LAGEMLSVAEHFLEQ | 101 | P49368 | |
| FVIQHHDLEGLEIAM | 3546 | O75592 | |
| RHLTEFVGLDIEMAF | 281 | P14868 | |
| GTVLLDMHANSIEEI | 176 | Q2Y0W8 | |
| LVATDIHLGFMEKDA | 16 | P49959 | |
| ILFHSSDGMLVLDAE | 226 | Q13326 | |
| VLLDAHMNAKIADFG | 156 | Q13131 | |
| ASSFLGLLEHVLAME | 406 | Q7Z7M1 | |
| DMVRFLLEAGADQEH | 386 | Q8IWZ3 | |
| HLIMAVRGQFSTDEL | 831 | P53675 | |
| KNAFGLHLIDFMSEI | 126 | Q15003 | |
| AHMDIFQNLAVDLDT | 2246 | A5YKK6 | |
| EQDMALNIHAFSAGL | 191 | Q5BKX6 | |
| AGFIASHMIVSLVED | 26 | O95455 | |
| LVENFGVQEDLMDLH | 86 | A6NLX4 | |
| MLFLEAEQGVTHITE | 336 | Q15111 | |
| EILETHGTMNFLGAE | 101 | P13682 | |
| QHDAQEFMAFLLDGL | 586 | O94966 | |
| EFMAFLLDGLHEDLN | 591 | O94966 | |
| ASSVFMEHELVLDGA | 1381 | Q96KV7 | |
| MEHELVLDGAVVSAS | 1386 | Q96KV7 | |
| LGESNVMDVLLAASH | 91 | O15062 | |
| DSVMDHLLAADVLLG | 2011 | Q8IZQ1 | |
| HDDFALDASILNVAM | 216 | O14924 | |
| FMVALGLVTTEHLEE | 281 | Q96EK2 | |
| EDTLLLHQAFEDAMD | 411 | Q8N2H3 | |
| HQFGMDLLLGDVQIS | 3011 | Q15413 | |
| QITLDVLADMGHEEL | 1051 | O95271 | |
| ALMDNIDTFIEHLFA | 206 | O14787 | |
| IDDLGHLHVMDTVFL | 231 | Q9NPG8 | |
| NGTVLLDMHANTLEE | 176 | Q6U841 | |
| VAGILLLHMSEEEAF | 896 | Q86TI0 | |
| DFQSEVLLSAMELFH | 1916 | Q6ZS81 | |
| AEVVLALDAIHSMGL | 196 | O75116 | |
| QILDSELFELMHQNG | 1031 | Q2NKQ1 | |
| IADHGQIDSMEQLVL | 106 | O95988 | |
| ISFVAGVLLLHMSEE | 1011 | O60343 | |
| GLEHLMDIFEREQIT | 886 | Q9H2K2 | |
| FFLESIAMHDIIAAE | 1296 | P78527 | |
| EVVLALDAIHSMGFI | 181 | Q13464 | |
| EHERSMLEGALTFLV | 756 | Q6ZT12 | |
| DLIGESVIMVAHFLQ | 156 | Q969M1 | |
| TFISEEMALHLDNGG | 236 | Q14CZ0 | |
| LLDGSNMSHKLFIED | 1126 | Q13395 | |
| HEQLVDLMLEAIQGA | 226 | Q14139 | |
| DLMLEAIQGAHFEDV | 231 | Q14139 | |
| MELHFTKDIVDAGLA | 531 | Q13769 | |
| VSHLLDLEEAGDMVA | 36 | P54821 | |
| GLSDFEMQRIHVAAA | 136 | Q8TE54 | |
| LHMDLSDIVEGILNA | 311 | Q8NFA0 | |
| NGLHMDLDTQDIFSL | 396 | Q9NYU2 | |
| DFLDALIVSMDVIQH | 106 | P13010 | |
| NLFEHELGALNMAAL | 1561 | Q5T200 | |
| LFVGLLMALTVHFEE | 151 | Q9NX78 | |
| GVEFSEEQLQAHLMS | 796 | Q5THJ4 | |
| EMTILHGGFLLAEQL | 11 | P57678 | |
| IRFGLMDVDTLHTVA | 231 | Q96NJ5 | |
| VGFMDHEAESVLAVV | 261 | O43795 | |
| DLEILETVMGQLDAH | 41 | Q9UQQ1 | |
| QETLHAMNVIGIFAE | 256 | Q12965 | |
| AEMLEDLHISQDATG | 481 | Q96D46 | |
| TALHLATEMEELGLV | 636 | Q00653 |